Do not mistake temptation for opportunity.

Generated Fri Mar 22 09:19:01 EDT 2019.

Ratings are relative rankings calculated by finding the lower bound of Wilson score confidence interval. A rating value close to 1 means a higher probablity of a stock's price high vs price open hitting or exceeding Calculated Target.

Today's mood: 0.4459958101704981

These 16 stocks represent the top 2% of all considered stocks. 2% = 12

• https://t.co/QpzIZ68ulC review I’ve been a member of Jason Bond Picks for 2 years and made some serious profits! $GPRO $FIT $PFE
• RT @CNBCFastMoney: Top technician @rsluymer says these two high dividend stocks are gearing up for a breakout $PFE $VZ https://t.co/2xzFF1e…
• Top technician @rsluymer says these two high dividend stocks are gearing up for a breakout $PFE $VZ https://t.co/2xzFF1eBPv
• As an Opioid Addict, You Don't Survive! You DIE OUT! #Allergan Has >1,300 Legal Matters. Trade The $agn Charts Kn… https://t.co/kPQ2EjSSlP
• .@novonordiskus has submitted its #diabetes pill for approval by the @US_FDA with a priority review voucher and mor… https://t.co/wpeAX2eK1S
• RT @StockTweetsHQ: A Mickey Finn_DYNAVAX TECHNOLOGIES $DVAX Share Price To Rise, CEO Announcement Of Advanced Buyout Talks With Pfizer $PFE…
• RT @StockTweetsHQ: A Lot Of Empty Flattery_CASTLIGHT HEALTH $CSLT CEO To Unveil Pfizer $PFE Buyout Offer As Early As Friday Following Talks…
• A Little Yeast Works Through The Whole Batch Of Dough_ALDER BIOPHARMACEUTICALS $ALDR CEO To Confirm Pfizer $PFE Buy… https://t.co/61SOEfFqzH
• @PaulTheMartian @SNCCLA Yes, gov is totally aware. 75% of the DOW is based on profit from pHARMa/HELLthcare. Reduci… https://t.co/atYP8srl0U
• $DIS $PFE $FDC $LLY $BMY $MPC $EPD $JNJ $PAA $KO $AIZ $FIS $OAK $EFX $SRE $ATH $WES $DVA $ABT $JPM $HPQ Largest MOC… https://t.co/magE5mBWCz
• https://t.co/pCc61dtcPr This student made $50K trading Jason Bond Alerts! FULL REVIEW! $PFE $EXPE $AMGN $BBRY
• RT @FlyOnTheWallHQ: Easy as ABC_NOVAVAX $NVAX To Be Scooped Up In Stock And Cash Transaction By Pfizer $PFE, Official PR Coming Early Next…
• RT @FlyOnTheWallHQ: Different Kettle Of Fish_PFIZER $PFE Share Price To Rise, Announcement Coming Of Acquisition Of Major British Based Big…
• Pfizer eyes Fierce 15 winner Vivet buy as gene therapy fever heats up. Will the collaboration lead to a curative ap… https://t.co/qCQGRgVqrv
• RT @StockTweetsHQ: A Nest-Egg_PRECIPIO $PRPO CEO To Release Details On Ongoing Acquisition Negotiations With Big Pharma Pfizer $PFE As Earl…
• #Biotechnology $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE… https://t.co/WV04qPetIS
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $SPX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $BSX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS
• RT @StockTweetsHQ: A Diamond Is Forever_VANDA PHARMACEUTICALS $VNDA CEO Will Confirm New Partnership Agreement With Pfizer $PFE As Early As…
• RT @StockTweetsHQ: A Game Of Two Halves_IOVANCE BIOTHERAPEUTICS $IOVA To Be Scooped Up In All Cash Transaction By Pfizer $PFE, Announcement…
• $AAPL $TRV $MSFT $HD $DWDP $INTC $NKE $V $IBM $WBA $CSCO $UTX $VZ $MRK $AXP $CVX $CAT $PG $MCD $MMM $UNH $JNJ $XOM… https://t.co/8zv5r7uqwh
• https://t.co/QpzIZ5QSX2 [review] I’ve been a member of Jason Bond Picks for 2 years and made some serious profits! $GPRO $FIT $PFE
• $QBIO Q BioMed Announced Strategic Partnership With SRI International for Formulation and Preclinical Development o… https://t.co/16BbleP0Cv
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/sGGioRcPG7
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/27UK2LtaiF
• RT @StockTweetsHQ: A Fool And His Money Are Soon Parted_LEXICON PHARMACEUTICALS $LXRX To Be Scooped Up In Cash And Stock Transaction By Pfi…
• RT @StockTweetsHQ: A Knight In Shining Armor_PROGENICS PHARMACEUTICALS $PGNX CEO To Announce Ongoing Secret Acquisition Negotiations With P…
• RT @Escells: Synthetic Biologics NYSE $SYN Upgraded H.C. Wainwright Buy $SYN In the last 3 months, 1 ranked analysts set 12-month price…
• RT @CNBCFastMoney: Top technician @rsluymer says these two high dividend stocks are gearing up for a breakout $PFE $VZ https://t.co/2xzFF1e…
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/cCWOVccdPB
• Synthetic Biologics, Inc. $SYN Pioneering Cutting-edge Research into Clinical Science Designed to Protect and Prese… https://t.co/DStu2cMk7z
• @greyzone513 @thlizrd @AuricGoldFinqer I also feel $pfe or other already offered too far from the mark. The raise… https://t.co/z3h4YEgNEo
• RT @ebcapital: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust @themotleyfool #stocks $BIIB , $LLY, $PFE , $JNJ #biotech #health https://…
• Short sale volume (not short interest) for $CPRX on 2019-03-21 is 46%. https://t.co/98fO0eTJ77 $ABT 36% $JNJ 32% $PFE 45% $SRPT 50%
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE… https://t.co/9i1I23miVr
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY $CELG $MRK $JNJ
• Tons of VC chasing bullshit into this hype cycle. Staying simple in my view. Eg: Proving in a prospective trial th… https://t.co/zo8I7yoZxa
• https://t.co/7LeaTJ9s2d $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/i0LXQHuVv4
• RT @BioinformaticsB: Pfizer takes stake in gene therapy company Vivet Therapeutics gains purchase option httpswww.firstwordpharma.comnode16…
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/rtYRt9hu0P
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/mPpvGqEiOm
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/uPV5cuthdR
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/hW8WSiKuQv
• RT @TickwatcherMF: Top #money flow today. Free stocks app https://t.co/B6pljuv3p6 $MBFI, $AAPL, $EFA, $XLK, $JNK, $AMZN, $IWM, $SPY, $FFIN,…
• Top #money flow today. Free stocks app https://t.co/B6pljuv3p6 $MBFI, $AAPL, $EFA, $XLK, $JNK, $AMZN, $IWM, $SPY,… https://t.co/v2HN4CpU0k
• RT @Cancer_bio: Merck KGaA Pfizer stop latestage study of PDL1 inhibitor Bavencio in ovarian cancer httpswww.firstwordpharma.comnode1630554…
• $PFE One of my old faves. inv. h&s happening. 43-43.3 area for the neckline and also top of channel. Eyes on for n… https://t.co/om8h0anM1W
• #Boeing 737 Pulse Stops! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk $luv… https://t.co/H27U6QOE44
• top money flow Thursday (share price x volume traded) - $AMZN $AAPL $BIIB $MU $AMD $NVDA $NFLX $BA $MSFT $DIS $FB… https://t.co/5ZqBbJ30KX
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/uaEHWiPAB5
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/Q5PTGmyiuD
• Short sale volume (not short interest) for $GSK on 2019-03-21 is 49%. https://t.co/ggc3HtU6q9 $AZN 43% $SNY 52% $NVS 52% $PFE 45%
• Short sale volume (not short interest) for $CNAT at 2019-03-21 is 54%. https://t.co/tbd1yHiS3E $IRWD 62% $VRTX 43% $PFE 45% $ICPT 42%
• $ABBV $AZN $MKGAF $MKGAY $MKKGY $PBYI $PFE $RHHBY Biotech Analysis Central "Biotech Analysis Central Pharma News: A… https://t.co/WzfiyxhMmt
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/HcpIbyiDdH
• most active stocks on Thursday - $AMD $MU $BAC $GE $AAPL $F $HBAN $PBR $ITUB $CAG $ACB $ECA $VALE $SIRI $BBD $WFC… https://t.co/ZBSt9Ir9bb
• MACD Crossover $MU, $SPY, $GE, $GDX, $GG, $CAG, $PFE, $JNK, https://t.co/enk69n2wuO
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $PFE $AMGN
• https://t.co/Ay4Yj8mjq7 < Who is Steven Dux ??? $JNJ $PFE $GSK $LLY
• RT @semodough: JP $SRPT positive long-term view on SRPT shares&maintain is pole position in micro-dystrophin (MD) space. Lingering question…
• JP $SRPT positive long-term view on SRPT shares&maintain is pole position in micro-dystrophin (MD) space. Lingering… https://t.co/ASL1gIs7HP
• M&T Bank $MTB Market Value Rose While Baillie Gifford & Company Has Cut Its Stake; Advisors Preferred Has Lowered I… https://t.co/wAOGDjm9oQ
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @MomentumBeast: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaste…
• RT @MomentumBeast: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/8p5…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @BehaviorFin: $CLLS $ALCLS When will we see sp back to $30 level? #TALEN and #ZncFng vs #crispr battle? $SGMO $CRSP $NTLA $EDIT $ALLO $P…
• RT @BehaviorFin: $CLLS $ALCLS Where is major part of #Cellectis' value? I begin to wonder whether biggest value of Cellectis is in human tr…
• RT @BehaviorFin: After buy out in #genetherapy of $ONCE, when would we see a buy out in #geneediting? $CLLS $ALCLS $SGMO $CRSP $NTLA $EDIT…
• RT @BehaviorFin: After buy out in #genetherapy of $ONCE, which area of next buy out? $ALNY $IONS $DRNA $ARWR $RGLS $MGEN $CLLS $ALCLS $SGM…
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/hGXowK9yUw
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/SoksZSdtRd
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/8V1XEaPTxr
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/wOkPKir5El
• $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University… https://t.co/fQhDZ0MsG0
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/U6OFizl2TQ
• https://t.co/cHUFotiHBx $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/UR4f70N9by
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• Take a Walk Ya #boeing Bully! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk… https://t.co/QEoWUdhlkW
• #Boeing Chairman & CEO Needs Ousting! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk… https://t.co/IiB55KMCSA
• RT @semodough: JP $SRPT positive long-term view on SRPT shares&maintain is pole position in micro-dystrophin (MD) space. Lingering question…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @semodough: JP $SRPT positive long-term view on SRPT shares&maintain is pole position in micro-dystrophin (MD) space. Lingering question…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• #Biotech Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More https://t.co/hlOkX8DAvO $BIIB $SAGE… https://t.co/ZnnyoCVFPY
• $JPM $SPGI $PFE $BA $AAPL: Dow 30 Stock Roundup: AAPL Refreshes Product Lineup, BA Wins $327M Navy Order: https://t.co/AiVveiE5rv
• It's Just Words At #Boeing! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk… https://t.co/RKD4wYkE98
• RT @StockTweetsHQ: Catch on_HALOZYME THERAPEUTICS $HALO CEO To Release Details On Pfizer $PFE Acquisition Negotiations Happening Now In NYC…
• RT @StockTweetsHQ: A Little Yeast Works Through The Whole Batch Of Dough_ALDER BIOPHARMACEUTICALS $ALDR CEO To Confirm Pfizer $PFE Buyout O…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/N8aFwtQesl
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/A9tAAtixF0 … $IBB $NVS $GILD $BMY $MRK $PFE $AMGN $SPY
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/lWDoPm1UCm
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/Wha44CMfDw
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/QzUVt6Mo3n
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/9b0cnmxFPg
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/SY3tEOlgQZ
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/zbrWOdOnzC
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/xSBAPlxdwC
• Interesting to see a $PFE option to buy a Paris-based #biotech company to expand its stake in the ever increasing a… https://t.co/NbhYke2AmJ
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• https://t.co/tmPfZbgmI2 $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/5EkBOXUarM
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• #Boeing's Crony Capitalism Thrives By Corruption $aapl $amzn $agn $brk $ba $bhc $crm $cmg $esrx $f $ge $gm $tsla… https://t.co/RvMFshWwdE
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• Missed yesterday's news? Here's everything for #pharma #marketers to know. #womenshealth #diabetes $NVO $PFE… https://t.co/eFJOn3a02C
• RT @semodough: JP $SRPT positive long-term view on SRPT shares&maintain is pole position in micro-dystrophin (MD) space. Lingering question…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• #Boeing's Crony Capitalism Thrives By Corruption $aapl $amzn $agn $brk $ba $bhc $crm $cmg $esrx $f $ge $gm $tsla… https://t.co/JgacTlpFH2
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…

• $GIS M30 gap n shake yesterday / bounce off 20 SMA today ... notice always a first candle R2G a good go signal https://t.co/uteVOC9it2
• Morgan Stanley Has Just Reaffirmed $49 Target Price Per Share on General Mills $GIS stock, While They’ve Also Reite… https://t.co/4fyOgVjgcb
• General Mills $GIS: Morgan Stanley Maintains Hold Rating Today, Has a Target of $49/Share https://t.co/yiBF1y7Cdc
• Morgan Stanley Has Just Reaffirmed $49 Target Price Per Share on General Mills $GIS stock, While They’ve Also Reite… https://t.co/uRa6fZBGQa
• Analysts at Morgan Stanley Reconfirmed their Past ‘"Hold"’ rating on Shares General Mills $GIS, Set a $49 PT https://t.co/TelnpBV46x
• $GIS https://t.co/Od396jbHmE
• RT @tpetruno: Packaged food stocks, one of Wall St's most unloved sectors, surge after Conagra beats on earnings. Big movers: Conagra $CAG…
• RT @LaMonicaBuzz: Another food company raised prices and its stock is soaring. ConAgra posts solid earnings, just like General Mills yester…
• Reaffirmed: General Mills $GIS Buy Rating Reiterated at Guggenheim; $56 Target in Place https://t.co/Rcqqu096bp
• TOday’s Movers: General Mills $GIS Stock Rating Reaffirmed by Guggenheim; $56 Target Price Indicates 11.91 % Potent… https://t.co/Mi5EYCTwTr
• 11.91 % to Target, Guggenheim Keeps ‘"Buy"’ Rating on General Mills $GIS Shares Today https://t.co/1ZPE4tHWre
• Breaking: General Mills $GIS Buy Rating Reaffirmed by Analysts at Guggenheim Today; The Target is $56 https://t.co/E35eo6aZua
• Thurs (3/21/19) 52 wk high w/vol abv 3-mth avg & Trading range > 90% (Min $5, Vol > 750K, Opt Vol in any strike > 1… https://t.co/e1Y5JF7vCw
• General Mills $GIS Shares Gap Up Following Better-Than-Expected Earnings https://t.co/cWMRUEwyCo
• $GIS technical alerts: Pocket Pivot, 180 Bullish Setup, MACD Bullish Signal Line Cross, Expansion ... https://t.co/Leh7VtIAoq
• General Mills $GIS Receives Positive Rating from Wells Fargo & Co https://t.co/61ds3qxzQj
• General Mills $GIS Receives Positive Rating from Wells Fargo & Co https://t.co/VODXaF0AMj
• General Mills, Inc. $GIS to Post FY2019 Earnings of $3.13 Per Share, Piper Jaffray Companies Forecasts https://t.co/2XzPVJU9jy #stocks
• General Mills, Inc. $GIS Forecasted to Post FY2019 Earnings of $3.13 Per Share https://t.co/Lq4YrPfplR
• General Mills, Inc. $GIS to Post FY2019 Earnings of $3.13 Per Share, Piper Jaffray Companies Forecasts https://t.co/ttB3TsxPSZ
• Piper Jaffray Companies Raises General Mills FY2019 Earnings Estimates to $3.13 EPS (Previously $3.06). https://t.co/7VSYdPcLRq $GIS #GIS
• Jefferies Financial Group Raises General Mills FY2019 Earnings Estimates to $3.13 EPS (Previously $3.09). https://t.co/lMRJWEn7YJ $GIS #GIS
• General Mills, Inc. $GIS Forecasted to Post FY2019 Earnings of $3.13 Per Share https://t.co/8HxFwcvgCi #stocks

• Memories Of "Marlboro Friday" $MO $BIIB https://t.co/sD9RIkld04
• @BeFullyInformed I'm being extra cautious this time around. Would rather hit singles & just a few doubles. Took to… https://t.co/Mp3A5Gdl8r
• $AAPL $AMD $MU $BAC $NVDA $AMZN $FB $MSFT $MO $NFLX $COTY $DIS $TSLA $BA $NKE $T $SQ $GE $JPM $INTC $BIIB $QCOM… https://t.co/5mLeYHTok6
• $AAPL $COTY $AMD $GE $MO $FB $BAC $NVDA $MRVL $MU $INTC Highest volume strikes https://t.co/oVckpIl4oq
• Unusual option activity alert: $MO 9x average daily volume, $NKE 5x, $DIS 4x, $GDX 4x, $OIH 4x, $XLK 4x, $AAPL 3x
• Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/NjJFPplJ1v
• RT @UPBOptionMil: Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/yN7DfsaIJc
• RT @UPBOptionMil: Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/yN7DfsaIJc
• $MO Altria Group, Inc. Daily Stock Price Summary From our Stock News Alerts App
• RT @UPBOptionMil: Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/yN7DfsaIJc
• RT @UPBOptionMil: Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/yN7DfsaIJc
• Check out these gains on options in the last 3 days - Option Team always on fire! Consistent wins for our members!… https://t.co/sXcVKyfhk3
• @UPBOptionMil @OMillionaires $mo buy is interesting. $bud (+Marty Barrington (from $mo)) + $mo (10% owner of bud) (… https://t.co/6N74UE6AxZ
• @SGottliebFDA Recession coming! Smoking on the rise. Juul unavailable in certain areas bc of FDA and libtard cities… https://t.co/7SkWChIdvI
• Tom Russo on Lessons from Global Value Investing at #VIP2 Conference @CFASocietyIndia $BRK.B $V $MA $AXP $HEINY… https://t.co/T3pRPGe46s
• RT @gekkostocks: Altria Has Already Doubled the $2.4 Billion CAD it Invested in Cronos Group - https://t.co/dnQglWEMi9 $CRON $MO $MJ $CRON.…
• $HBAN $URBN $EQT $TGT $FOXA $BIIB $CAG $RF $AAPL $NFLX $PEP $KEY $VIAB $FSLR $BK $AMD $DIS $ILMN $UNP $WY $MO $IBM… https://t.co/Td33yh4Dkd
• Analysts at Wells Fargo Reconfirmed their Past ‘Buy’ rating on Shares Altria Group $MO, Set a $65 TP https://t.co/Mk9KXpmKtR
• New York: Altria Group $MO Stock Has Just Had Its "Buy" Rating Reiterated by Wells Fargo. Shares now Have a $65 Tar… https://t.co/QGyfESVIjt
• Breaking: Wells Fargo Reconfirms $65 Target On Altria Group $MO Shares, Reconfirms Their Original Buy Rating https://t.co/B202FiRdVA
• Breaking: Altria Group $MO Buy Rating Reaffirmed at Wells Fargo Today; The Target Price per Share Given is $65 https://t.co/i2loxOygmy
• Analysts See $0.92 EPS for Altria Group, Inc. $MO https://t.co/fss0J7UCPn
• Altria Group, Inc. $MO EPS Estimated At $0.92 https://t.co/BvwnLmWyCp
• Altria Group, Inc. $MO Analysts See $0.92 EPS https://t.co/exRQSeem6m
• Altria Group, Inc. $MO Analysts See $0.92 EPS https://t.co/zBonLIinU1
• Interesting $MO and $CRON https://t.co/Q7j5n71wIr
• RT @UPBOptionMil: Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/yN7DfsaIJc
• RT @UPBOptionMil: Some of todays most active stock options 3.21.19 $AAPL $NVDA $AMD $MO $FB $DISCA https://t.co/yN7DfsaIJc
• Altria Group $MO Raised to Hold at ValuEngine https://t.co/YNOSbTvoMU
• Altria Group $MO Raised to Hold at ValuEngine https://t.co/OQG4SvFx8e
• $MO goes ex-div today.
• RT @pharris667: Interesting $MO and $CRON https://t.co/Q7j5n71wIr
• Altria Group $MO Price Target Increased to $66.00 by Analysts at Bank of America https://t.co/kjf55CqDTn
• Altria Group $MO PT Raised to $66.00 https://t.co/wXiMVjWLfB
• As Transocean LTD $RIG Shares Declined, Holder Jupiter Asset Management LTD Upped Holding; Wespac Advisors Holds Po… https://t.co/xgZfCoOm28
• Rothschild Investment Has Upped By $314,188 Its Altria Group $MO Holding; MEDIPAL HOLDINGS ORDINARY SHARES $MEPDF S… https://t.co/yhldrunF7a
• Altria Group Sees Unusually High Options Volume $MO https://t.co/DCB1HlGGkT
• Altria Group Sees Unusually Large Options Volume $MO https://t.co/tT893xqhYP #stocks
• Altria Group Sees Unusually Large Options Volume $MO https://t.co/S2rGxLZ9PW
• Kanawha Capital Management Upped Altria Group $MO Position; Siga Technologies $SIGA Has 2.25 Sentiment https://t.co/oC2NbMmlOl

• $BMY $CELG Novartis S1P titration patent a real issue? Likely not so much https://t.co/balSpgMTf2
• https://t.co/TNT3Eir2dp $CELG $BMY
• $DIS $PFE $FDC $LLY $BMY $MPC $EPD $JNJ $PAA $KO $AIZ $FIS $OAK $EFX $SRE $ATH $WES $DVA $ABT $JPM $HPQ Largest MOC… https://t.co/magE5mBWCz
• RT @PRB51: $BMY $CELG Novartis S1P titration patent a real issue? Likely not so much https://t.co/balSpgMTf2
• @DavidSchawel $MSFT for sure. Also, if I remember correctly, $BMY $BAC $GM. (Still own $MSFT. Sold rest in ~2011)
• RT @HalftimeReport: We get so many great questions each & every day, and as much as we want to answer ALL of them, sometimes we just don't…
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $SPX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $BSX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS
• $QBIO Q BioMed Announced Strategic Partnership With SRI International for Formulation and Preclinical Development o… https://t.co/16BbleP0Cv
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/sGGioRcPG7
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/27UK2LtaiF
• #Biotechnology $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE… https://t.co/WV04qPetIS
• RT @Escells: Synthetic Biologics NYSE $SYN Upgraded H.C. Wainwright Buy $SYN In the last 3 months, 1 ranked analysts set 12-month price…
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/cCWOVccdPB
• Synthetic Biologics, Inc. $SYN Pioneering Cutting-edge Research into Clinical Science Designed to Protect and Prese… https://t.co/DStu2cMk7z
• Wild week for bios.. $DERM $BIIB and now $CNAT blows up w/ NF trial.. coming close to the end of the qtr// Starb… https://t.co/UobSyLKP3X
• RT @FlyOnTheWallHQ: Elementary, My Dear Watson_BRISTOL-MYERS SQUIBB $BMY BOD To Release Details On Acquisition Negotiations With Unnamed NY…
• EPS for Bristol-Myers Squibb Company $BMY Expected At $0.94 https://t.co/JbGxhO3RYs
• Bristol-Myers Squibb Company $BMY Analysts See $0.94 EPS https://t.co/5AdU7Bn72V
• $0.94 EPS Expected for Bristol-Myers Squibb Company $BMY https://t.co/Kn0LfTR3zZ
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY $CELG $MRK $JNJ
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/rtYRt9hu0P
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/mPpvGqEiOm
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE… https://t.co/9i1I23miVr
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/uPV5cuthdR
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/hW8WSiKuQv
• RT @UPBOptionMil: Some of todays top open interest changes 3.21.19 $AAPL $BMY $CAG $ALLY $VALE $PM $F $FIS $QCOM $CELG $DB $BBBY https://…
• #Boeing 737 Pulse Stops! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk $luv… https://t.co/H27U6QOE44
• Cheap put options and hedges: $CRON puts cheaper than 89% of history, $BMY 89%, $SLV 89%, $MGM 89%, $LVS 89%, $WDC 89%, $EBAY 89%
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/HwiQ0myqNg
• Green day $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS $UNH $VZ… https://t.co/qUAs205VXt
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/wu65v3lpJC
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/1LZWLo82cU
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/XFnslTcpob
• TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• Carroll Financial Associates Inc. Reduces Stake in Bristol-Myers Squibb Co (BMY) https://t.co/Th4zdEyQ8P $BMY #stocks #stockmarket
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/uaEHWiPAB5
• @alfred_vinci I don’t think $BMY is saying pipeline is worth $45B. Theyre saying theyre paying $15B for a pipeline… https://t.co/tvarZX6BZA
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/HcpIbyiDdH
• (1of2) Why is $BMY/ $CELG spread narrowing? 1) starboard came out w/197pg deck that made me think their thesis is… https://t.co/mfgPI4nHRD
• My God $NKTR is so dependent on $BMY using IV NKTR-214 in #Melanoma with fading results - and here’s $RHBBY Genente… https://t.co/5dGESsXuoz
• My God $NKTR is so dependent on $BMY using IV NKTR-214 in #Melanoma with fading results - and here’s $RHBBY Genente… https://t.co/etFtG7I8Jk
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @MomentumBeast: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaste…
• RT @MomentumBeast: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/8p5…
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @BehaviorFin: $CLLS $ALCLS When will we see sp back to $30 level? #TALEN and #ZncFng vs #crispr battle? $SGMO $CRSP $NTLA $EDIT $ALLO $P…
• RT @BehaviorFin: $CLLS $ALCLS Where is major part of #Cellectis' value? I begin to wonder whether biggest value of Cellectis is in human tr…
• RT @BehaviorFin: After buy out in #genetherapy of $ONCE, when would we see a buy out in #geneediting? $CLLS $ALCLS $SGMO $CRSP $NTLA $EDIT…
• RT @BehaviorFin: After buy out in #genetherapy of $ONCE, which area of next buy out? $ALNY $IONS $DRNA $ARWR $RGLS $MGEN $CLLS $ALCLS $SGM…
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/hGXowK9yUw
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/SoksZSdtRd
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/8V1XEaPTxr
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/wOkPKir5El
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $PFE $AMGN
• $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University… https://t.co/fQhDZ0MsG0
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/U6OFizl2TQ
• Results from Phase 1 testing epacadostat $INCY with ipilillumab $BMY showed an acceptable safety profile (no more A… https://t.co/FuFFSoi8eX
• Douglass Winthrop Advisors Has Raised Its Position in Bristol $BMY by $532,746; Regal Investment Advisors Holding I… https://t.co/ISdDUj1zIR
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• #Boeing Chairman & CEO Needs Ousting! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk… https://t.co/IiB55KMCSA
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @fezziwig2008: My God $NKTR is so dependent on $BMY using IV NKTR-214 in #Melanoma with fading results - and here’s $RHBBY Genentech & E…
• Grupo Aval Acciones y Valores $AVAL Upgraded By BidaskScore; Bryn Mawr Trust Company Has Cut Its Bristol Myers Squi… https://t.co/ePYzOFnoaw
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/A9tAAtixF0 … $IBB $NVS $GILD $BMY $MRK $PFE $AMGN $SPY
• Stifel $AMRN Who Would The Buyer Be? Multiple Big Pharma and Large Biotech’s Have Expressed Interest in The CV Spac… https://t.co/ImNoLdyjHJ
• RT @fezziwig2008: My God $NKTR is so dependent on $BMY using IV NKTR-214 in #Melanoma with fading results - and here’s $RHBBY Genentech & E…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/N8aFwtQesl
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/lWDoPm1UCm
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/Wha44CMfDw
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/QzUVt6Mo3n
• $CELG $BMY The April 12th vote for the $74 Billion Bristol-Myers Squibb (BMY) - Celgene (CELG) merger is fast appro… https://t.co/KbjMrzAjGp
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $CELG $BMY The April 12th vote for the $74 Billion Bristol-Myers Squibb (BMY) - Celgene (CELG) merger is fast appro… https://t.co/oYzLDr2vrf
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/zbrWOdOnzC
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/xSBAPlxdwC
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…

• $SYF: Synchrony to Announce First Quarter 2019 Financial Results on …: https://t.co/ub6R7j6h51
• $SYF high OI range is 31.50 to 33.00 for option expiration 03/22/2019 #maxpain #options https://t.co/YmCkj4lAxs https://t.co/Re18DPQIqO
• NIO Inc. NYSE $NIO Named The World's Most Innovative Companies for 2019 https://t.co/fxaYx64vMp $APTV $DLPH… https://t.co/vD27Wlqt4D
• Synchrony Financial $SYF Lifted to “Buy” at Zacks Investment Research https://t.co/rmrgk2hdJ3
• Synchrony Financial $SYF Upgraded by Zacks Investment Research to “Buy” https://t.co/Ev0ytB7ddb
• Virtu Financial Cut By $807,116 Its Synchrony Finl $SYF Holding; Salem Communications $SALM Has 0.58 Sentiment https://t.co/kYUZ4hpUEx
• Baidu $BIDU Holder Cantillon Capital Management Trimmed Position; Norman Fields Gottscho Capital Management Has Dec… https://t.co/j8hqvaQ7IT
• Braun Stacey Associates Has Cut Zebra Technologies Cl A $ZBRA Holding; Roystone Capital Management LP Has Lowered I… https://t.co/NCGsVm24wF

• @permabear_uk $BSX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $BSX
• Boston Scientific $BSX settled +0.8% at $38.15. FPE 21s... not cheap. Note the double floor from Nov/Dec' in the $3… https://t.co/Zx92483E9Z
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE… https://t.co/9i1I23miVr
• $NKE $CTAS $BSX $MDT $UAA $TIF $FL $CHRW $FOSL $ETFC $GE $FCX $NAVI $CELG $SWKS $UA $JNJ $CPB $GM $PG $DO $PCG… https://t.co/35OYBszx2H
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/wu65v3lpJC
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/1LZWLo82cU
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/XFnslTcpob
• @qualitycompound Hi Andrew, better picks in that sector, $DHR $BSX even that old warhorse $ILMN, also distinction n… https://t.co/v9AF9Fmokf
• $BSX: Forecast sales for Belo Sun Mining Corp are now forecast to rise this year. (https://t.co/FYExi2hvhF)
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University… https://t.co/fQhDZ0MsG0
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…

• $10.71 Billion in Sales Expected for American Airlines Group Inc $AAL This Quarter https://t.co/l7KvJA8ejg
• American Airlines Group Inc $AAL Expected to Announce Quarterly Sales of $10.71 Billion https://t.co/x7tkXuIjRY
• $AAL Learn more about the zigzag #Elliottwave pattern here for free https://t.co/CXJfJicmen https://t.co/4wrNQ1mEJv
• $AAL Correction from the highs seen as a zigzag pattern https://t.co/dL3i1NImLh #Elliottwave
• https://t.co/xiqUoE9DFG < Davis Martin explains his trading strategy. $SLB $AAL $HALO $IBN
• American Airlines Group Inc. $AAL EPS Estimated At $0.61 https://t.co/LV7NWAwdng
• American Airlines Group Inc. $AAL Analysts See $0.61 EPS https://t.co/zNnuiKc09q
• Analysts See $0.61 EPS for American Airlines Group Inc. $AAL https://t.co/b9kHnciqK9
• $AAL A triple bottom with true divergence after all the $BA nonsense? Don't mind if I do. $34 strike calls are .15… https://t.co/d7nHStcam7
• $AAL American Airlines correcting 2013 IPO lows with next swing target at $14.9 - $20.4 https://t.co/dL3i1NImLh… https://t.co/8OmRGAV2na
• $AAL American Airline pilots expect to test 737 MAX software fix in Boeing simulator https://t.co/mw2hRKwZhz
• Mark Zuckerberg and Facebook Inc. knew before the Cambridge Analytica scandal article published by The Guardian.… https://t.co/PUI5hByHGz
• $AAL #Elliottwave View: American Airlines corrects cycle from 2013 IPO lows https://t.co/dL3i1NImLh https://t.co/duychl8dJU
• The #FTSE100 was dominated by #mining companies including #Fresnillo @AntofagastaPLC and @AngloAmerican #LSE $VALE… https://t.co/hg6nIbGJyD
• Analysts See $1.75 EPS for PVH Corp. $AAL Coverage https://t.co/eJIhUPd1UU
• $KHC $AAL Buffetts Course Reversal on Airlines Sparks Talk of Acquisition via https://t.co/dU2ohMsCEH
• $AAL $DAN $BLDR $AAWW $CJ: 5 Stocks Basking in the Glory of Recent Analyst Upgrades: https://t.co/tRcW38e55u
• Market Fallers: Aviva plc, Anglo American plc, AstraZeneca plc, BAE Systems plc, Barclays PLC & BP plc -… https://t.co/H0aBxzM3A5
• BidaskClub top 50 #StronglyBought $INTC $TMO $ZTS $SCCO $LBRDA $MTCH $NVO $EC $EW $HDB $LYG $MCO $MDLZ $RBS $ISRG… https://t.co/8QKd1Bppnx
• $AAL Elliott Wave View: Correcting 2013 IPO Lows https://t.co/dL3i1NImLh #Elliottwave #Trading #Americanairline https://t.co/YWvIgwm4EO

• Nwq Investment Management Company Lowered Its Hess $HES Position; Opus Investment Management Upped Oneok $OKE Hold… https://t.co/0nuffavC6A
• $AMZN $SQ $MSFT $IBM $AVGO $KMI $IEP $O $WPC $VTR $OKE $SPY $DIA $QQQ $EPR so true https://t.co/YoaQ0XYxHt
• RT @StockTweetsHQ: My Cup Runneth Over_LOCATION BASED TECHS $LBAS Confirmation Of Share Buy Back Program To Begin As Early As This Week htt…
• RT @StockTweetsHQ: A Fate Worse Than Death_ACETO CORP $ACET CEO Confirmation Coming Of Merger Discussions With Top US "HouseHold Name" Comp…
• Dividend Stocks For Dummies: https://t.co/dO8ZRBPX4B $WMB $CTL $HCP $NOV $OKE $GM $VLO $HST $MAT $T
• Q1 2019 Earnings Forecast for ONEOK, Inc. $OKE Issued By US Capital Advisors https://t.co/GnktddYzrW
• Q1 2019 Earnings Forecast for ONEOK, Inc. $OKE Issued By US Capital Advisors https://t.co/KrYxpIo8gx
• FY2020 Earnings Estimate for ONEOK, Inc. $OKE Issued By US Capital Advisors https://t.co/2kltJnGAAo
• FY2020 EPS Estimates for ONEOK, Inc. $OKE Lifted by US Capital Advisors https://t.co/Zdkv9DZwd7
• Visionary Asset Management Has Trimmed By $2.04 Million Its Oneok New $OKE Stake; Blue Hills Bancorp $BHBK Sentimen… https://t.co/VwMJP6NdIJ
• $OKE open interest for maturity 03/29/2019. High put=62.50 High call=69.50 #maxpain #options https://t.co/U6VWtKbtrM https://t.co/jSk3jKUbUc
• $OKE is Bullish above $68.72. Trade near $68.72 https://t.co/corsbAeMia https://t.co/qWDvULwZSE
• $OKE $BSTC $BBY $DRI: 4 Top Stocks to Buy for Superb Earnings Growth: https://t.co/cjra0lwXpI
• RT @tradespoon: $OKE is Bullish above $68.72. Trade near $68.72 https://t.co/corsbAeMia https://t.co/qWDvULwZSE

• RT @teshen8lin: Chipmakers are on pace for their best first quarter @CNBC $mu $avgo $nvda $qcom $intc https://t.co/kfsZDR6M96
• $INTC another cool got it gave it to u check the posts https://t.co/UPDmkx34UF
• RT @IAM_magazine: IPR filings show Intel is embroiled in litigation with China's premier research body $INTC https://t.co/YL9fOsu5C3 https:…
• IPR filings show Intel is embroiled in litigation with China's premier research body $INTC https://t.co/YL9fOsu5C3 https://t.co/NwhRmxlVtt
• $AAPL $AMD $MU $BAC $NVDA $AMZN $FB $MSFT $MO $NFLX $COTY $DIS $TSLA $BA $NKE $T $SQ $GE $JPM $INTC $BIIB $QCOM… https://t.co/5mLeYHTok6
• $AAPL $COTY $AMD $GE $MO $FB $BAC $NVDA $MRVL $MU $INTC Highest volume strikes https://t.co/oVckpIl4oq
• Apple Debuts a Host of Product Upgrades -- With No Fanfare Whatsoever. Why is #Apple downplaying its latest batch o… https://t.co/k3k2ZhGTbX
• RT @HedgeFundTips: KEY TABLE: Everything you need to know about the NASDAQ top 30 weights $QQQ components - Earnings Estimates/Revisions an…
• On April, 25 The EPS for Intel Corporation $INTC Expected At $0.87 https://t.co/o1arkyMj3f
• $0.87 EPS Expected for Intel Corporation $INTC as of April, 25 https://t.co/1I8eetMWsG
• RT @DomenickBeskos: #Insight - semicondoctor sales are in free fall - worst since 2008..! CEO’s Of semies keeps promising rebound in 2. h…
• $AAPL $TRV $MSFT $HD $DWDP $INTC $NKE $V $IBM $WBA $CSCO $UTX $VZ $MRK $AXP $CVX $CAT $PG $MCD $MMM $UNH $JNJ $XOM… https://t.co/8zv5r7uqwh
• I had a very candid conversation with @intel CCG sales exec Steve Long about the F-series CPUs and how the company… https://t.co/f13vac1nKP
• $INTC Intel - Q3 2019 Intel Corporation Earnings Conference From our Stock News Alerts App
• $INTC Intel - Q2 2019 Intel Corporation Earnings Conference From our Stock News Alerts App
• $INTC Intel - Q1 2019 Intel Corporation Earnings Conference From our Stock News Alerts App
• https://t.co/7LeaTJ9s2d $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/i0LXQHuVv4
• $0.87 EPS Expected for Intel Corporation $INTC https://t.co/isfd0PsEbs
• Intel Corporation $INTC Analysts See $0.87 EPS https://t.co/vPfCsMzz9Z
• EPS for Intel Corporation $INTC Expected At $0.87 https://t.co/fT2L5KeCDs
• EPS for Intel Corporation $INTC Expected At $0.87 https://t.co/P91N9EyhtN
• Green day $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS $UNH $VZ… https://t.co/qUAs205VXt
• $INTC 17-May-19 ATM Implied Vol Increases +1.6% to 25.3. Straddle Implies a Move of ±8.1% https://t.co/9evCV4SwcW
• $INTC inverted hammer on a The 20 MA
• #Boeing 737 Pulse Stops! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk $luv… https://t.co/H27U6QOE44
• The chip groups feature some stocks that are either approaching a buy point or are in the 5% buy zone. $SMTC $AVGO… https://t.co/LHLQTIhps5
• RT @dannyvena: Apple Debuts a Host of Product Upgrades -- With No Fanfare Whatsoever. Why is #Apple downplaying its latest batch of product…
• Credit Capital Investments Has Decreased By $920,000 Its Intel $INTC Position; Carmignac Gestion Has Trimmed Incyte… https://t.co/8LMFmjXOZr
• top money flow Thursday (share price x volume traded) - $AMZN $AAPL $BIIB $MU $AMD $NVDA $NFLX $BA $MSFT $DIS $FB… https://t.co/5ZqBbJ30KX
• The Dividend Mantra Way by Jason Fieber: https://t.co/kPg9pfvHMA #dividends $PG $KO $STX $WDC $VLO $INTC $TXN
• PR: AOPEN unveils Chromebox Commercial 2 $GOOG, $INTC, $TRI https://t.co/GpjridCcba https://t.co/gX2hh7jRsz
• PR: @Ubisoft Announces The PC Specifications For Assassin's Creed III Remastered $AMD, $INTC, $NVDA… https://t.co/KRq3qraz99
• Weekly Stock Market Review Week #12: https://t.co/cUlRnZLnjL $AAPL $NVDA $MU $AMZN $FB $GOOGL $NFLX $SPY $QQQ… https://t.co/YdUztgyWb4
• Traders Buy Intel $INTC on Weakness on Insider Selling https://t.co/ZN6xgMdtIe
• Zacks: Brokerages Expect Intel Co. $INTC to Announce $0.87 EPS https://t.co/Lasx3dlV1m #stocks
• Zacks: Brokerages Expect Intel Co. $INTC Will Announce Earnings of $0.87 Per Share https://t.co/A6hb3z0hnh
• $qcom Qualcomm $aapl $spy $qqq $tsla $intc $mu $amd $avgo $ba $fb $ge $mchp $nvda $txn $amzn $goog $crm $tgt $sbux… https://t.co/7NXNVEgWCq
• $NVDA is with 40% gain since this bullish forecast for Nvidia issued 3 months ago: https://t.co/fCnMIohqfG…… https://t.co/WExgQloSrj
• RT @thiruvar: The chip groups feature some stocks that are either approaching a buy point or are in the 5% buy zone. $SMTC $AVGO $INTC $MCH…
• RT @TweakTown: PR: AOPEN unveils Chromebox Commercial 2 $GOOG, $INTC, $TRI https://t.co/GpjridCcba https://t.co/gX2hh7jRsz
• #Intel $INTC BidaskScore is Increased to StronglyBought https://t.co/qRkcZFPSD5
• RT @TweakTown: PR: @Ubisoft Announces The PC Specifications For Assassin's Creed III Remastered $AMD, $INTC, $NVDA https://t.co/lrYItZ2a9I…
• RT TweakTown PR: Ubisoft Announces The PC Specifications For Assassin's Creed III Remastered $AMD, $INTC, $NVDA… https://t.co/EcMlgNYWLf
• RT TweakTown RT TweakTown: PR: AOPEN unveils Chromebox Commercial 2 $GOOG, $INTC, $TRI https://t.co/mIVnLA7ayZ https://t.co/Li6sKQZ2QQ
• RT TweakTown PR: AOPEN unveils Chromebox Commercial 2 $GOOG, $INTC, $TRI https://t.co/mIVnLA7ayZ https://t.co/Li6sKQZ2QQ
• RT TweakTown RT TweakTown: PR: Ubisoft Announces The PC Specifications For Assassin's Creed III Remastered $AMD,… https://t.co/HOi6VdUVsi
• BidaskClub Upgrades Intel $INTC to “Strong-Buy” https://t.co/6onYkMkuYV
• BidaskClub Upgrades Intel $INTC to “Strong-Buy” https://t.co/My8cwtNDQ6
• IF I were you I didn't check out this tweet $SPY will rise anyway $INTC $STM $TXN $NFLX $JPM $GS $smh $spy $spx… https://t.co/GeFMpQuNCU
• $SMH: DAILY 1 YEAR VOLATILITY CHART as shares trend higher. 30% off on any bulk data order in March 2019. $NVDA… https://t.co/EO1vtYVGHA
• https://t.co/cHUFotiHBx $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/UR4f70N9by
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fyp7Zfw
• https://t.co/tmPfZbgmI2 $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/5EkBOXUarM
• #Boeing's Crony Capitalism Thrives By Corruption $aapl $amzn $agn $brk $ba $bhc $crm $cmg $esrx $f $ge $gm $tsla… https://t.co/RvMFshWwdE
• According to my technicals, there is a 45-55% chance they come in and buy the dips, unlike the 80-85% probability t… https://t.co/HNyzzAJNGo
• $MQBKY $INTC $AMD $NVDA $MU: Macquarie Group Bought Up Qualcomm Stock and Sold Intel, AMD, Nvidia, Micron: https://t.co/TykVdRI2Ch
• #Boeing's Crony Capitalism Thrives By Corruption $aapl $amzn $agn $brk $ba $bhc $crm $cmg $esrx $f $ge $gm $tsla… https://t.co/JgacTlpFH2
• Take a Walk Ya #boeing Bully! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk… https://t.co/QEoWUdhlkW
• #Boeing Chairman & CEO Needs Ousting! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk… https://t.co/IiB55KMCSA
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• BidaskClub top 50 #StronglyBought $INTC $TMO $ZTS $SCCO $LBRDA $MTCH $NVO $EC $EW $HDB $LYG $MCO $MDLZ $RBS $ISRG… https://t.co/8QKd1Bppnx
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• https://t.co/w7VO00tJnP $AAPL $AXP $BA $CAT $CSCO $CVX $DIS $DWDP $GS $HD $IBM $INTC $JNJ $JPM $KO $MCD $MMM $MRK… https://t.co/rD1fqEPEEW
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• MY $xlf own index fighting with 200 day MA $INTC $STM $TXN $NFLX $JPM $GS $smh $spy $spx $AAPL $BAC $PG $YHOO $CHK… https://t.co/GBAg7kbUXa
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• Potential reversal trade levels they sport a 80% probability factor $SPY, $QQQ, $NDX, $DIA, $IWM, $NFLX, $FB,… https://t.co/zRX8SQFmI7
• @PatrickMoorhead @FTC $APPL downside risks are now surfacing. If you don't accept FRAND and tend to violate it at a… https://t.co/jS3ygYOqRF
• Top Buy Stocks: $AAPL, $INTC, $MRVL, $NEM, $NWSA, $VTR, $WPG, $WSM https://t.co/YK7HUDXy1U
• $bpth $nio $tlry $apha $nbev $igxt $ogen $acb $ogrmf $mnga $tops $msft $amzn $fb $sgen $nvda $igcc $mnkd $mysz… https://t.co/xd8T3LV0S9
• $tlry $apha $nbev $igxt $ogen $acb $ogrmf $mnga $tops $msft $amzn $fb $sgen $nvda $igcc $mnkd $mysz $nlst $cei $xon… https://t.co/xUIsSwIJa0
• It's Just Words At #Boeing! $aapl $amzn $agn $brk $ba $bhc $crm $cmg $dis $esrx $f $ge $gm $tsla $mnk $myl $mrk… https://t.co/RKD4wYkE98
• What Can We Expect Following a Intel $INTC Upgrade By BidaskScore? https://t.co/Vpb7vxXfXA
• Should Investors Turn Their Attention to Intel $INTC? BidaskScore Has Just Upgraded the Stock https://t.co/NXfG0BH4mD
• Is Intel $INTC now a ‘Buy’ After a BidaskScore Upgrade? https://t.co/hKiEsFviCm
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/Wha44CMfDw
• little divergence between Percent Of Stocks Above 50-Day Average $MMFI and the $SPY $INTC $STM $TXN $NFLX $JPM… https://t.co/4VSD8lhtxm

• RT @theflynews: Fly Intel: Wall Street's top stories for Thursday $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES htt…
• Friday: $WDC, $MU, $AMD, $EA, $NVDA, $AAPL, $BIIB, $FB, $SQ
• RT @EricJhonsa: $AMD now up 20% on the week. Aside from the Stadia news (not too surprising) and $MU's earnings, short-covering is probably…
• RT @teshen8lin: Chipmakers are on pace for their best first quarter @CNBC $mu $avgo $nvda $qcom $intc https://t.co/kfsZDR6M96
• $SPY Support and Resistance (Pivots) for Fri 3/22/19: $BABA $JD $JPM $XOM $MCD $QCOM $MU $SBUX $TWTR $SPY $QQQ… https://t.co/dZmW4Vp1NT
• RT @IBDinvestors: Chip Stocks Lead Another Stock Market Rally $MU $SMH $AAPL $DRI https://t.co/uOt0kr9IUF
• RT @cfromhertz: *PHILADELPHIA SEMICONDUCTOR INDEX RISES ABOVE CLOSING-DAY RECORD $SOX $SOXX $SMH $AMD $NVDA $MU $AMAT $AVGO $LRCX $MRVL
• RT @cfromhertz: *PHILADELPHIA SEMICONDUCTOR INDEX RISES ABOVE CLOSING-DAY RECORD $SOX $SOXX $SMH $AMD $NVDA $MU $AMAT $AVGO $LRCX $MRVL
• Scan results - Expansion Breakout today: $GIII $CAG $DRI $BPY $MU $ACIA $QRVO $WPM $AAPL $BPR $MDCO $ANET $VCYT… https://t.co/DAwlfyI2PO
• Scan results - MACD Bullish Signal Line Cross today: $GIII $CAG $DRI $BPY $MU $BNFT $QRVO $BPR $FIS $EHTH $WIFI… https://t.co/CKEXwENFaz
• @TweetLeni Today $MU looked like it broke out on a three month chart to me. I concur that that’s not a break out. I’m waayy long semis too.
• RT @TommyThornton: @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inventor…
• @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inv… https://t.co/9PIpzDNzHe
• $AAPL $BAC $JPM $MU: U.S. Stocks Finish Higher, Lifted by Tech Sector: https://t.co/jtyFLl5FZN
• RT @MichaelsFinTwit: @VolatilityQ @kerberos007 Here's a collection of $MU post earnings notes from JPM, Credit Suisse, BofAML, and Wells Fa…
• $MU - Micron: Awful Guidence https://t.co/ZPNrOJrjw9
• $SPY $QQQ $IWM $DIA $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES Top stock stories for Thu… https://t.co/yUPUmyzpI8
• Thurs (3/21/19) earnings +/- % from OR 30-min high, Up/Avg Gain of today’s thirteen 30-min bars, G/L % in final 30-… https://t.co/s6qXKyOkLM
• TOday’s Movers: Micron $MU Stock Rating Reiterated at Goldman Sachs; $42 Target Price Indicates -4.52 % Potential https://t.co/EncJPGOixI
• @VolumeDynamics With $SPX up 1+% to YTD High $VIX should have a 12 handle That's me eyeballing it Thursday was an… https://t.co/06suGV0nuA
• $CAG gapped up on #earnings and just kept running, closing up over 12%, making them Thursday's top performing $SPX… https://t.co/BAIM005aY4
• (Cont'd... Part 2 of 3) $EB: 308.3%AV; +4.1% $CLNE: 276.9%AV; +8.9% $TCNNF: 272.2%AV; +10.9% $AVXL: 270.3%AV; +4.7%… https://t.co/xow1KGxBAV
• 36.39 % to Target, Stifel Nicolaus Maintains ‘"Buy"’ Rating on Micron $MU Shares Today https://t.co/RoZ8C1Vj7v
• @VolatilityQ @kerberos007 Here's a collection of $MU post earnings notes from JPM, Credit Suisse, BofAML, and Wells… https://t.co/9kZLiiYUhJ
• @AOTtrades @anandsan @cabe_merritt $MU PEG?
• Here is a snapshot of the current market. Remember to join the discussion room for live analyses, trade recaps, and… https://t.co/4pUyvEUABs
• $MRVL $AAPL $NVDA $AMD $CX $MU $FL $BAC $MSFT $GPOR $SNBR $WPM $TWLO $CZR $LYG $AIG $NKE $SQ Unusual options activi… https://t.co/M1FAzgUuIV
• $DJIA $SPX $COMP $MU $AAPL: The S&P 500 Rose Despite Biogen’s 29% Plunge: https://t.co/nsZuETkWwy
• #NASDAQ MOST #VOLUME $AMD +7.57% [$27.89, Volume: -15% ~ 126,816,575] $MU +5.18% [$43.99, Volume: +122% ~ 84,722,7… https://t.co/55QgYmANx5
• Why The Fed Stopped Raising Rates, It's Probably Not What You Think https://t.co/J59ly9HeGF $spy $acad $aapl $nflx $mu $nvda $amd $iwm
• RT @TeresaTrades: $MRVL $AAPL $NVDA $AMD $CX $MU $FL $BAC $MSFT $GPOR $SNBR $WPM $TWLO $CZR $LYG $AIG $NKE $SQ Unusual options activity htt…
• RT @EricJhonsa: $AMD now up 20% on the week. Aside from the Stadia news (not too surprising) and $MU's earnings, short-covering is probably…
• RT @cfromhertz: *PHILADELPHIA SEMICONDUCTOR INDEX RISES ABOVE CLOSING-DAY RECORD $SOX $SOXX $SMH $AMD $NVDA $MU $AMAT $AVGO $LRCX $MRVL
• $AAPL $AMD $MU $BAC $NVDA $AMZN $FB $MSFT $MO $NFLX $COTY $DIS $TSLA $BA $NKE $T $SQ $GE $JPM $INTC $BIIB $QCOM… https://t.co/5mLeYHTok6
• $DRI, $BPY, $MU, $BPR, $FIS, $EHTH https://t.co/VHYcXbHkkM
• $DRI, $BPY, $MU, $ACIA, $BPR https://t.co/Tpxn9dzMCW
• $CSIQ, $SCS, $DRI, $MU, $ZUO https://t.co/RF3bTkReo1
• $AAPL $COTY $AMD $GE $MO $FB $BAC $NVDA $MRVL $MU $INTC Highest volume strikes https://t.co/oVckpIl4oq
• Follow me and comment any chart request and I’ll break them down for you $SPY $AAPL $MU $NFLX $DIA $FB $XLF
• Why The #Fed Stopped Raising Rates, It's Probably Not What You Think $SPY $IWM $MU $AMD $AAPL $NVDA $ACAD $NFLX https://t.co/IeJl8xpP7s
• $CAG $MU $DRI $NVDA $MBT $AAPL $RLGY $ORCL $MSFT $CVS $F $LUV $T $NKE $CMCSA $CTAS $AMZN $GM $MUR $GOOGL $NFLX… https://t.co/RatS8UYZSS
• RT @TommyThornton: @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inventor…
• RT @theflynews: Fly Intel: Wall Street's top stories for Thursday $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES htt…
• +21 Points Called Out Today! A Lot Of Great Setups! Trade With Us Live! @RockSolidTrader & @cml41987 $YANG +1.15… https://t.co/SjOIQAoeZl
• Wall Street's top stories for Thursday $BIIB, $AAPL, $MU, $AMZN, $SNAP, $GES, $F https://t.co/b2YbCsGt97
• RT @breakingoptions: $SMH $MU we did it again too expensive to play $MU eps so we used the $SMH 200+% https://t.co/pkuNoMw808 @SpartanTrad…
• #TRICKTRADES is grassroots in originality and proper trading education, why go to some pseudo traders room when you… https://t.co/m0zBEHIVDc
• https://t.co/zLvcpWQalH $60 loss in $MU Earnings play. Went in expecting to lose all 100 if earnings were bad. Earnings came out good bu...
• RT @HalftimeReport: BIG show coming up! On the agenda: $AAPL $CMG $BIIB $MU and much more! https://t.co/RED6GCKkBZ
• $MU missed earnings... up 9% today. Can someone explain?
• RT @kerberos007: Wow.. What was that? From Risk-Off across all asset class to FOMO buying in 10 minutes after the open,, $MU earnings mis…
• Best alert of the day : $MU. But the funny part is, it did’n get triggered and hit my target price. Missed the en… https://t.co/flBENdwRpB
• @chung55 Just $study info :) $SPY since 12/26, been mentioning it all the way up. $MU reply yest: It didn’t go do… https://t.co/vbhaAj3DCh
• Sell $MU. Rarely do the FM gang, especially in direct defiance of such a massive bull run - like the semis waged to… https://t.co/QUAOpI0zzy
• Agree or Disagree Litecoin is way under the radar in the Crypto Community? $BTC $BCH $BSV $ETH $ETC $XRP $XLM… https://t.co/5MAtgJDDTy
• RT @TommyThornton: @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inventor…
• RT @TommyThornton: @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inventor…
• $MU Almost everyone got this one wrong. https://t.co/UktHioeq11
• 1️⃣2️⃣Biggest Market Gainers $OOIL $SPI $SRNE $CURLF $DCIX $SCON $SOLO $SLNO $LIFE $VSI $STNE $CAG $TOPS $FLKS… https://t.co/cVgZuxmVsn
• RT @SunriseTrader: $MU earnings beat gap up. It would be OK if based between 200ma and 200ema. Stop raised on the Let it Ride shares http…
• @TweetLeni My data shows 10 day average @ 27 mil with today at 84 mil.for $MU.
• Golden Cross, coming in hot on the daily. #Litecoin $BTC $BCH $BSV $ETH $ETC $XRP $XLM $HOT $VET $LTC $EOS $NEO… https://t.co/qLy1yNTL6v
• RT @WallStJesus: ORDER FLOW SENTIMENT IN ACTIVE NAMES: $AAPL $AMD $MU $NVDA $MSFT $FB $BAC $AMZN $NFLX $DIS $COTY $TSLA $BA $SQ $BIIB https…
• RT @theflynews: Fly Intel: Wall Street's top stories for Thursday $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES htt…
• RT @WallStJesus: ORDER FLOW SENTIMENT IN ACTIVE NAMES: $AAPL $AMD $MU $NVDA $MSFT $FB $BAC $AMZN $NFLX $DIS $COTY $TSLA $BA $SQ $BIIB https…
• RT @WallStJesus: ORDER FLOW SENTIMENT IN ACTIVE NAMES: $AAPL $AMD $MU $NVDA $MSFT $FB $BAC $AMZN $NFLX $DIS $COTY $TSLA $BA $SQ $BIIB https…
• RT @theflynews: Fly Intel: Wall Street's top stories for Thursday $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES htt…
• He Got Gold Right (And it Soared 407%) - https://t.co/sCmplYsgH1 $MU $AMD $GS $BA $AMD $NVDA $NFLX $BKNG $BIDU $FB
• $CAG $MU $DRI $NVDA $MBT $AAPL $RLGY $ORCL $MSFT $CVS $F $LUV $T $NKE $CMCSA $CTAS $AMZN $GM $MUR Major News-BULL… https://t.co/x3rg6Vpkob
• RT @behindthebid: What's happening in stocks today (03/21): - $LEVI: IPO Listed Today: 10 Times Oversubscribed $BIIB: Sad News as Halts Alz…
• RT @traderstewie: Will be adding $MU to the #PowerEarningsGap if it closes at or near session highs today! So far so good! https://t.co/g…
• Evening Most Tweeted Big Caps, check out Gambiste Top 10: $TSLA $BIIB $CGC $MU $SNAP $EA $TWTR $SQ $DRI $PCG https://t.co/k3uyuEbRpJ
• $MU Micron's Latest Earnings Signal the Worst Could Soon Be Over for Chipmakers https://t.co/AyqedyUn7z
• @kerberos007 The Semi action today was insane. $WDC up 10% on $MU massive inventory build and production cuts becau… https://t.co/M8PNXazTvD
• RT @luke_sosnowski: #TRICKTRADES is grassroots in originality and proper trading education, why go to some pseudo traders room when you can…
• #SCREENED $TWTR $FB $MU $DIS $T $VZ $JPM $GS $WFC $GILD $WBA $LVS $NIO $IYT $DIA $IWM $TNA
• @SL_Steamroom Haven't seen noticable $MU action at their party day :(
• @Quarry_Rock Lol perm turd $mu really caught people by surprise
• $MU powered +9.6% to $43.99, after lousy earnings... but numbers marginally 'better than expected'. Today's close a… https://t.co/5Esi8KO2mM
• @Quarry_Rock $mu getting bought like: https://t.co/izSlXfNAym
• @OptionsMike Sounds like Cramer on $MU!
• Golden Cross, coming in hot on the daily. #Litecoin $BTC $BCH $BSV $ETH $ETC $XRP $XLM $HOT $VET $LTC $EOS $NEO… https://t.co/HAjHIOPC04
• $MU: "You're welcome, Mr. Market." $SPX $SPY $SMH $QQQ
• RT @RampedDaytrader: +21 Points Called Out Today! A Lot Of Great Setups! Trade With Us Live! @RockSolidTrader & @cml41987 $YANG +1.15 $NVD…
• Todays Top Gainers: $SPI $SRNE $SLNO $DCIX $SOLO $SCON $CAG $VKTX $TOPS $STNE $ZSAN $OPK $MU $AMD $EA $WTI $TTOO $CRMD $WDC
• RT @paranoidbull: @kerberos007 The Semi action today was insane. $WDC up 10% on $MU massive inventory build and production cuts because “ba…
• $WDC $MU $AMD $EA $ALGN $NVDA $ATVI $SWKS $LRCX $AMAT $AAPL $MCHP $FOXA $NXPI $FOX $SNPS $KLAC $TTWO $LULU $XLNX… https://t.co/3XVYEOFZ5V
• $WDC $MU $AMD $QRVO $STX $ANET $NVDA $SWKS $LRCX $AMAT $IPGP $AAPL $MCHP $SNPS $KLAC $FIS $FTNT $XLNX $ADSK $NTAP… https://t.co/SvWBpcse0B
• Analysts' Perspective on $BIIB, $MU, $CMPGY, $JWN, $EXR, $SDXAY https://t.co/QPwKildr2m
• Largest gainers today 3/21/2019 on my Watch List were: $NVDA $ANET $ALGN $EA $MU https://t.co/QiM1A23xrl
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• @spec_v2 @Casmoden @KevinMulhall @ant_gtree @Dayman58 @jonmasters $MU up nearly 10% today :)
• RT @MrAaronKlein: $NVDA didn’t even look this morning. Should have stuck with $AMD trade too. Sick entries on both! $MU killer gains lo…
• @SpartanTrading @MommasOptions Nice trades on $AMD, $MU and $NVDA today them semi conductors ripped
• Notice a theme? $study $SPY $ROKU $MU $NVDA $TSLA
• $MU https://t.co/bKDSoCoAJr
• RT @MrAaronKlein: $ROKU $MU $SPY c off the open
• RT @MrAaronKlein: $ROKU $MU $SPY c off the open
• RT @socalchef00: Closed out my 2 earnings plays $WSM and $MU strangles for +25% each. Opened $FDX vertical and $WSM vertical spreads, shoot…
• RT @TommyThornton: @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inventor…
• Few Options highlights today (Follow Thru!): $MU 43c 280%, 44c roll swing (will see) $AAPL 200c 200%+ $SPY 286c 200… https://t.co/pw9D8XzEmt
• Few Equity highlights today: $GII Long 2pts Pivot cross into res. $AAPL 1.5pts flag break $AMD long aside options p… https://t.co/2yywLgtSnO
• $NVDA : No words on this today we had calls 1 min after the open sympathy play to $MU 2 layers today started with 1… https://t.co/XCQ3SOTOKV
• Check out these gains on options in the last 3 days - Option Team always on fire! Consistent wins for our members!… https://t.co/sXcVKyfhk3
• RT @TommyThornton: $MU inventory rose +$500M q/q to a >20-year high of 155 days. CEO says cutting 5% of production will lead to 2nd half r…
• RT @racernic: $MU. nice move. cheap stock. Unliked by Wall st. Upside target met. Into R. BUT if can add greens tomoro=nice upside awaits.…
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• @Quarry_Rock I think $MU went up cause it got beaten up so much. So all the people looking at it, jumped in joy and… https://t.co/YirNEcguwc
• RT @Dicken80239758: @Quarry_Rock Lol perm turd $mu really caught people by surprise
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• RT @theflynews: Fly Intel: Wall Street's top stories for Thursday $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES htt…
• RT @socalchef00: Closed out my 2 earnings plays $WSM and $MU strangles for +25% each. Opened $FDX vertical and $WSM vertical spreads, shoot…
• Relative strength, breakouts $OPK $SOLO $VSI $VKTX $SRNE $MU $WDC $STNE $OPK $LRCX $PAYC $ISRG $NVDA $ALGN $AZO… https://t.co/PuzGhYfrVb
• Had $NKE reported last night it would be up 9% like $MU
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• RT @TommyThornton: @htsfhickey Fred $MU inventory at 155 days and 20 year high. Cutting production by 5% won’t bring into balance inventor…
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• ALERT!! The Best Stock Investment For 2019 Is Progressive Care $RXMD This could be the best stock investment most o… https://t.co/ElLnDRTQiR
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• This could be the best stock investment most of us may ever make. It is THE #1 stock to buy right now, easily one o… https://t.co/q9Gu94Y3qQ
• @spec_v2 @Casmoden @KevinMulhall @ant_gtree @Dayman58 @jonmasters I can buy a LOT of CPUs, GPUs and DRAM assuming I… https://t.co/Td5RghTLW4
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• @spec_v2 @Casmoden @KevinMulhall @ant_gtree @Dayman58 @jonmasters > Let's I'm long $MU....
• $MU finally rated A by Schwab again... optimistic.. for now anyway
• @traderstewie very impressive! lost a little more than I would have liked on $MU, but thankfully still had enough f… https://t.co/03olVDqD92
• RESULTS/GAINERS - $5K TO $340k - LINK IN BIO $SPI $SRNE $OTLK $PRAN $AMD $MU $FUV $UAVS $DCIX $LMB $FTEK $SLNO… https://t.co/7mCgoHGTys
• Fantastic interview on $mu earnings and outlook by ceo Sanjay mehrotra on cnbc’s squawk on the street now on the in… https://t.co/WPTUgSag8d
• $MU https://t.co/5uB4Y0rPAN
• Posibles niveles de $MU #TRMX https://t.co/p8DizHFQym
• Summit Redstone Partners Gives Micron $MU Shareholders a Gift With Today’s Upgrade https://t.co/uRe5EyNCI3
• Micron $MU Receives a Higher Rating From Summit Redstone Partners. Is it Time to Buy Shares? https://t.co/fvZ3flsu5t
• Summit Redstone Partners Decides to Upgrade Micron $MU. Will Other Analysts Follow Suit? https://t.co/nKy3bwGwjZ
• Summit Redstone Partners Finally Upgrades Micron $MU Stock https://t.co/x6jj4ZB7WD
• RT @TrueBubbleHead: #GamePlan for Friday *It's Friday, think next week's options! *watch futures indicators *if strong, think $TWTR, $LULU…
• Having a trusted team on your side will make all the difference when investing. Have you tried OptionAlarm yet? Fre… https://t.co/pAUFrsVcqc
• #GamePlan for Friday *It's Friday, think next week's options! *watch futures indicators *if strong, think $TWTR,… https://t.co/AsAg7I7Y4Y
• 21 MAR 2019 - Evening Update | Technology Stocks $MU @ $43.99 1-Week Return: 14.53% Combined Score: +22.2 Sentiment… https://t.co/QT0lb9epFZ
• Recent trade idea recap $MU moved up to 9.10% since post - 46.00 to follow - other ideas LE M ABBV SQ PYPL MSFT O… https://t.co/HQehl4V1EK
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• @NitzaBarky $mu ????
• RT @behindthebid: What's happening in stocks today (03/21): - $LEVI: IPO Listed Today: 10 Times Oversubscribed $BIIB: Sad News as Halts Alz…
• Nice Day on $MU, Trying To Finish The Week Strong https://t.co/8iRxlfWj2S via @YouTube
• Sell-signal detected for 15 stocks: $CRM $CME $CERN $FTNT $MU $AIG $LRCX $URBN $AMD $VZ $CAG $BIIB $PXD $DRI $MKC
• Friday March 22nd watchlist: $SRNE $MU $AMD $NKE $ATVI $BAC $DCAR $TGTX $SOLO $NIO $APOP $SBOT https://t.co/MlcnphKBIm
• Friday 22-Mar Earnings R2G watch: $CAG, $MU, $DRI @AOTtrades https://t.co/xiV6YlxpGe
• @ld_rusk Haha analyst are the biggest morons around. Sadly they can sometimes move prices. Just like that analyst f… https://t.co/hywvFxy8fi
• RT @IBD_DChung: In The Market: @MicronTech rises after quarterly results, yet earnings in FY 2019 (Aug.) are still seen falling 40% to $7.1…
• RT @BartVanTrading: watchlist: $CSIQ $MU $NKE $NFLX $GES
• RT @NitzaBarky: $MU https://t.co/5uB4Y0rPAN
• @traderstewie $MU PEG.
• You'd be surprised how hard it this is to do. $XLK $FB $MU https://t.co/3LMEDGeAnj
• @FTC @JoeSimonsFTC @FTCPhillips @RKSlaughterFTC Apple doesn't accept FRAND since they have violated it at all point… https://t.co/7yN3LL4IdA
• top money flow Thursday (share price x volume traded) - $AMZN $AAPL $BIIB $MU $AMD $NVDA $NFLX $BA $MSFT $DIS $FB… https://t.co/5ZqBbJ30KX
• Does $CAG have @petenajarian energy ⚡️? $GES $DRI $MU https://t.co/3eOTbetZXa via @YouTube
• Does $CAG have @petenajarian energy ⚡️? $GES $DRI $MU https://t.co/NoN6i7b9O2 via @YouTube
• RT @NitzaBarky: $MU https://t.co/5uB4Y0rPAN
• RT @ThePitBoss16: Micron Earnings Beat Expectations, Lowers Capital Expenditure $SPX $MU $NVDA $QQQ https://t.co/uO7ZQN5aDp https://t.co/ZE…
• Agnes projected $MU would out-perform the NASDAQ, it outperformed the NASDAQ by 4.18%, Did you outperform the NASDA… https://t.co/szCgkfAdIo
• Some have complained that $MU is wasting money buying back its falling stock, In last 6 months ending 2/28, $MU re… https://t.co/Qt51jvfNzj
• Jim Cramer Slides To Dark Side On China Tariffs $DIA $MU #TrumpFail #disaster https://t.co/5wtlJibH5G
• stocks with a high open interest of naked puts - $CELG $AAPL $PBR DIS $SNAP $BBBY $CZR $AMD $MU $COTY $AMD $MSFT $T… https://t.co/ioKR0hqRWD
• Weekly Stock Market Review Week #12: https://t.co/cUlRnZLnjL $AAPL $NVDA $MU $AMZN $FB $GOOGL $NFLX $SPY $QQQ… https://t.co/YdUztgyWb4
• $NVDA is with 40% gain since this bullish forecast for Nvidia issued 3 months ago: https://t.co/fCnMIohqfG…… https://t.co/WExgQloSrj
• RT @TommyThornton: $MU inventory rose +$500M q/q to a >20-year high of 155 days. CEO says cutting 5% of production will lead to 2nd half r…
• $MU Nice earnings pop and run! https://t.co/EE3tFmCcsZ
• Micron $MU Rating Kept by Needham Today https://t.co/nGo9Y9rROL
• Why Needham Has Just Restated Their "Hold" Rating For Micron $MU Shares https://t.co/J3znY5b7HO
• Needham Reiterates Hold Rating for Micron $MU stock. What’s the Best Move for Investors? https://t.co/32mDEgyIy2
• Needham Reconfirms Its "Hold" Rating on Micron $MU Shares Today https://t.co/xH0gf65U7Z
• $MU Makes an Outsized Move 9.6%. The 22-Mar-19 Option Straddle Expiring Tomorrow Implies a ±6.5% move https://t.co/OnNouwqK90
• most active stocks on Thursday - $AMD $MU $BAC $GE $AAPL $F $HBAN $PBR $ITUB $CAG $ACB $ECA $VALE $SIRI $BBD $WFC… https://t.co/ZBSt9Ir9bb
• $qcom Qualcomm $aapl $spy $qqq $tsla $intc $mu $amd $avgo $ba $fb $ge $mchp $nvda $txn $amzn $goog $crm $tgt $sbux… https://t.co/7NXNVEgWCq
• RT @investitute: $MU bulls triple their money https://t.co/9xVFJsSXdI
• RT @InvResDynamics: $AAPL gets an upgrade with absolutely no indication that it's fundamentals are getting worse and the CEO is incompetent…
• Micron Technology $MU Stock Price Up 9.6% Following Earnings Beat https://t.co/JbplABYS1Y
• Market has lost the plot, ignoring fundamentals. Disaster waiting to happen? #semis $mu Biggest short covering rall… https://t.co/50dArxQXXr
• MACD Crossover $MU, $SPY, $GE, $GDX, $GG, $CAG, $PFE, $JNK, https://t.co/enk69n2wuO
• RT @aboutheoptions: Recent trade idea recap $MU moved up to 9.10% since post - 46.00 to follow - other ideas LE M ABBV SQ PYPL MSFT ORCL…
• RT @TrueBubbleHead: #GamePlan for Friday *It's Friday, think next week's options! *watch futures indicators *if strong, think $TWTR, $LULU…
• $MU The Ratings Game: Micron stock surge leads chips to near record high levels https://t.co/XDKDQCdA8a
• Thursday top % gainers >$10 by volume $AMD $MU $CAG $WDC $ATVI $AMAT $TME $EA $ON $STNE $WPM $DRI $STX $LRCX $PVTL… https://t.co/OfsV4SwO4S
• Micron Technology $MU Upgraded to Buy by Standpoint Research https://t.co/BgpUZiSfTD
• Micron Technology $MU Upgraded at BidaskClub https://t.co/zXdGCFoF2V
• $AAPL $MU: Stocks Edge Higher As Apple-Lead Tech Rally Ripples Through Global Markets: https://t.co/wfbBQxUf2k
• $AAPL $MU: Dow Futures Tumble As European Factory Output Hits 2013 Low, Bunds Touch 0%: https://t.co/iMv7XHI4fn
• $MU earnings call transcript: https://t.co/nNEbXxbOGZ
• RT @theflynews: Fly Intel: Wall Street's top stories for Thursday $BIIB $AAPL $MU $F $AMZN $SNAP $LEVI $WMT $SRNE $DRI $DXCM $CSIQ $GES htt…
• most active stock options Thursday AM - $AAPL $MU $BAC $AMD $NVDA $NFLX $JPM $AMZN $FB $BA $MSFT $SQ $TSLA $BIIB… https://t.co/ImiJTjfoMT
• RT @IBDinvestors: Chip Stocks Lead Another Stock Market Rally $MU $SMH $AAPL $DRI https://t.co/uOt0kr9IUF
• trending stocks $AMD, $XLF, $MU, $SPY, $EEM, $AAPL, $QQQ, $GDX, https://t.co/Vy4usAvgod
• Micron $MU Had "Sell" Changed By Citigroup With $30 Target Of Stock. https://t.co/pwNjoD4xwd
• $SMH: DAILY 1 YEAR VOLATILITY CHART as shares trend higher. 30% off on any bulk data order in March 2019. $NVDA… https://t.co/EO1vtYVGHA
• RT @GreenStocks2016: “MUELLER IS... BATMAN!” $spy $spx $aapl $fb $tsla $c $amzn $nflx $googl $dia $indu $dia $qqq $ndx $iwm $eem $jpm $gs…
• RT @GreenStocks2016: “MUELLER IS... BATMAN!” $spy $spx $aapl $fb $tsla $c $amzn $nflx $googl $dia $indu $dia $qqq $ndx $iwm $eem $jpm $gs…
• “MUELLER IS... BATMAN!” $spy $spx $aapl $fb $tsla $c $amzn $nflx $googl $dia $indu $dia $qqq $ndx $iwm $eem $jpm… https://t.co/J5PULyvQmj
• As Netapp $NTAP Stock Declined, M&T Bank Has Lowered Stake; Kentucky Retirement Systems Decreased Micron Technology… https://t.co/qjST6tAOw2
• RT @TommyThornton: "New Micron" as a reminder $MU CEO bought back significant amount of stock 30% higher
• IF I were you I didn't check out this tweet $SPY will rise anyway $INTC $STM $TXN $NFLX $JPM $GS $smh $spy $spx… https://t.co/GeFMpQuNCU
• The $MU CEO sounds like he's on top of it..... Will persst Long $MU
• RT @MichaelMOTTCM: Why The Fed Stopped Raising Rates, It's Probably Not What You Think https://t.co/J59ly9HeGF $spy $acad $aapl $nflx $mu $…
• $AMD $LSCC $NVDA $MU $XLNX: Chipmakers on Fire: 3 Under-the-Radar Stocks to Win: https://t.co/7ZUCYlUVAx
• The Street’s Key Stock Analysts Research Reports: $AAPL, $COP, $CUBE, $DPLO, $INAP, $MU, $… https://t.co/odTiAhsrCA
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fyp7Zfw
• $MQBKY $INTC $AMD $NVDA $MU: Macquarie Group Bought Up Qualcomm Stock and Sold Intel, AMD, Nvidia, Micron: https://t.co/TykVdRI2Ch
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• Jump Trading LLC Stake in Micron Technology INC $Put $MU Decreased by $3.10 Million https://t.co/alfVSCNuYZ
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• Morning Most Tweeted Big Caps, check out Gambiste Top 10: $TSLA $BIIB $TWTR $CGC $AMD $MU $DRI $ES $FB $CVS https://t.co/k3uyuEbRpJ
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• RT @UPBOptionMil: Some of todays top open interest changes 3.22.19 $SNAP $NIO $AAPL $INTC $TEVA $MRK $GPRO $MU $BAC $JD https://t.co/xe5fy…
• Watching: $AAPL $ZUO $UNIT #FIS $PDD $HIBB $IMMP $MU $M
• MY $xlf own index fighting with 200 day MA $INTC $STM $TXN $NFLX $JPM $GS $smh $spy $spx $AAPL $BAC $PG $YHOO $CHK… https://t.co/GBAg7kbUXa
• $MU:[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 8, 1, 0, 0, 4, 2, 1, 0, -1, 0, 0, -1] Average: 0.7272727272727273 length: 22
• RT @jimcramer: #StockoftheDay $MU is likely to continue trading sideways in the weeks ahead https://t.co/oVKPkerSSg
• @cwags1278 $MU Took February peak and opened new extension higher toward $52 - $55 area as long as it remain above 3/8 low.
• @NorthmanTrader I set a alert up on TV on $NDX & I couldn’t believe how quickly it got hit. $MU, $AMD, $NVDA ripping faces off
• @PatrickMoorhead @FTC $APPL downside risks are now surfacing. If you don't accept FRAND and tend to violate it at a… https://t.co/jS3ygYOqRF
• RT @firstadopter: DRAMeXchange memory index takes another leg down overnight and hits another new low #fundamentals $MU https://t.co/z7AwcJ…
• We highlight the best trades on the #NYSE ,#NASDAQ and the world of #crypto - $SPY $SPX $TSLA $AAPL $AMZN $NVDA… https://t.co/RS0iM4Ch8m
• $bpth $nio $tlry $apha $nbev $igxt $ogen $acb $ogrmf $mnga $tops $msft $amzn $fb $sgen $nvda $igcc $mnkd $mysz… https://t.co/xd8T3LV0S9
• RT @ApproTrade: $MU selloff seems to be accelerating, sensibly.
• $mu selling off !! Going much lower my friend. https://t.co/NbSXvmERht
• $MU selloff seems to be accelerating, sensibly.
• $MU: Micron Earnings Surprise a Huge Positive for Top Semiconductor …: https://t.co/NqrTSjUB4c
• RT @firstadopter: DRAMeXchange memory index takes another leg down overnight and hits another new low #fundamentals $MU https://t.co/z7AwcJ…
• RT @firstadopter: DRAMeXchange memory index takes another leg down overnight and hits another new low #fundamentals $MU https://t.co/z7AwcJ…
• RT @WarrenBuffetHQ: This could be the best stock investment most of us may ever make. It is THE #1 stock to buy right now, easily one of th…
• DRAMeXchange memory index takes another leg down overnight and hits another new low #fundamentals $MU https://t.co/z7AwcJegas
• RT @WarrenBuffetHQ: This could be the best stock investment most of us may ever make. It is THE #1 stock to buy right now, easily one of th…
• $tlry $apha $nbev $igxt $ogen $acb $ogrmf $mnga $tops $msft $amzn $fb $sgen $nvda $igcc $mnkd $mysz $nlst $cei $xon… https://t.co/xUIsSwIJa0
• RT @WarrenBuffetHQ: This could be the best stock investment most of us may ever make. It is THE #1 stock to buy right now, easily one of th…
• RT @GreenStocks2016: TURKISH LIRA NOW IN FULL RECESSION $USDTRY $spy $spx $aapl $fb $tsla $c $amzn $nflx $googl $dia $indu $dia $qqq $ndx…
• RT @GreenStocks2016: TURKISH LIRA NOW IN FULL RECESSION $USDTRY $spy $spx $aapl $fb $tsla $c $amzn $nflx $googl $dia $indu $dia $qqq $ndx…
• Market is green when you dont trade. How many of you feel the same? #stocks #options #trading #Daytrader $appl… https://t.co/SVa2akeZFI
• TURKISH LIRA NOW IN FULL RECESSION $USDTRY $spy $spx $aapl $fb $tsla $c $amzn $nflx $googl $dia $indu $dia $qqq… https://t.co/TjVFXRUUi9
• RT @racernic: $MU. nice move. cheap stock. Unliked by Wall st. Upside target met. Into R. BUT if can add greens tomoro=nice upside awaits.…

• $SPY Support and Resistance (Pivots) for Fri 3/22/19: $GE $UPS $DIS $SNAP $ROKU $CMG $CAT $X $BIIB $CVS $BIDU… https://t.co/onooBX6s8m
• $CBD $CVS CVS Selling CBD Products, Curaleaf Stock Skyrockets https://t.co/pf90Duny5a
• RT @apppro1: @GuyAdami $CVS @cvspharmacy is also one of the main pharmacies - specialty pharmacies - that supplies #Epidiolex. $GWPH ONLY #…
• @GuyAdami $CVS @cvspharmacy is also one of the main pharmacies - specialty pharmacies - that supplies #Epidiolex.… https://t.co/QLFrd7G0sr
• @timearbitrage @WallStCynic $ABCS is the only one. They have an OTC approved topical pain product that has actual i… https://t.co/ZadUvlPeR2
• $CVS lovin it... more tomorrow
• RT @CNBCTheExchange: Tasty returns for $DRI, $AAPL's reported revenue grab from publishers, $CVS cashes in on cannabis and a down-and-dirty…
• $CVS apparently the bear pattern is not confirmed. Prices continue to rise. https://t.co/UuBjkm4eND
• Why these #Stocks are reportedly in the minds of the best investors, $SPY, $CVS, $SU #MoneyMaker #StockTrading:… https://t.co/Mq85UCDX7O
• $SPY $SQ $NTNX $CVS $HUYA We still have many positions open that were alerted on Feb 8th. It can take a lot of work… https://t.co/0OCFCysB79
• FastMoney helping out with pre Mad Money push of Curaleaf and $CVS connect. More pumping the latter may get that nu… https://t.co/fR40TuMrJy
• $CAG $MU $DRI $NVDA $MBT $AAPL $RLGY $ORCL $MSFT $CVS $F $LUV $T $NKE $CMCSA $CTAS $AMZN $GM $MUR $GOOGL $NFLX… https://t.co/RatS8UYZSS
• $CAG $MU $DRI $NVDA $MBT $AAPL $RLGY $ORCL $MSFT $CVS $F $LUV $T $NKE $CMCSA $CTAS $AMZN $GM $MUR Major News-BULL… https://t.co/x3rg6Vpkob
• CVS: A Case To Buy Shares Now $CVS https://t.co/1DbnVHNk9s $ANTM
• @jimcramer Even bfore interview it was crazy to see ppl short it with a PE of 10-11 at present earnings level. CVS… https://t.co/q1XykkpxOb
• @jimcramer Bought it after spotting the Dark Pool buying it last week ;-) $CVS
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• $CVS to sell CBD products in 800 stores in 8 states https://t.co/NAT6pwfbES
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• $CVS: CVS Health CEO on reducing costs: Billions in value opportunity is ‘in front of us’: https://t.co/MY49zGa1Ny
• RT @FlyOnTheWallHQ: A Bird In The Hand Is Worth Two In The Bush_CVS HEALTH CORP $CVS CEO Release Details of Pending Merger With Unnamed Nas…
• CVS has started selling cannabis-based products in 8 states https://t.co/er7Mbd33jO via @CNBC $CVS
• RT @syedaftab6: $CVS now selling CBD and stock is way under priced. CBD $TLRY $CGC $ACB
• So $CVS won’t sell tobacco but they’ll sell cannabis? https://t.co/g54oc1VHWa
• @WolfOfWeedST Where's $CVS at? The largest seller of CBD products...
• RT @rightviewrob: @jimcramer $CVS - great interview with CVS Health CEO tonight. Stock has retraced 62% of 2009/2015 range, at triangle sup…
• @jimcramer $CVS - great interview with CVS Health CEO tonight. Stock has retraced 62% of 2009/2015 range, at triang… https://t.co/1x5hT0AHUL
• CVS Health Corp (NYSE:CVS) Shares Bought by Addison Capital Co https://t.co/yZQCALZpcQ $CVS #stocks #stockmarket
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• @jimcramer $CVS daily technicals are amazing. Going to 60 quick
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• $CVS $ZS $ZEN $ZBRA $WSR: Cramer Remix: Levi’s stock is too rich to buy after its high-flying IPO: https://t.co/QRlTE8a1tA
• Don't buy $CVS because its stocking #CBD. That's like buying $CASY because they just stocked your favorite beer! Fo… https://t.co/739YhGFEvf
• Our top stocks for this year $PYPL $V $SQ $CVS $CRM $GS $DIS $CBRE
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• $CURA. $CVS.... omg CVS Distribution of CBD Products Sends Curaleaf Shares Soaring https://t.co/u2xOuTXGq1
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• $CVS slow and steady rise back great stock for the next 6 years
• @jimcramer I like $cvs as value but I don’t know about their concept stores. I’m not going to trust medical advice… https://t.co/CFc0YAUs8d
• @jimcramer Based on what I can research, $CVS is one of the most undervalued stocks in the market today. Fair value… https://t.co/yVMYgiaXnu
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• @jimcramer Honestly, no. I don’t really see the vision. I like plenty of your stock ideas - I am just having troubl… https://t.co/md9BbnAVEt
• RT @rightviewrob: @jimcramer $CVS - great interview with CVS Health CEO tonight. Stock has retraced 62% of 2009/2015 range, at triangle sup…
• RT @ItzYaBoiiAsh: $vrus 911 buy. 10q coming ah today? Better load up!!! Ka-ching $aapl $DIS $amd $CVS $cron $GHHC $inkw $INND $shmp $LFAP…
• RT @BenjaminA_Smith: Great session for Curaleaf $CURA $CURLF , obviously. Yesterday's ER / $CVS deal was a defining event that could move i…
• If u don't believe me @cvs I've got miracle home radiation kits to sell u. @wsj @cnbc #Stocks $CVS The only people… https://t.co/i08aNaRAdL
• $CVS role The 20 MA time to go LONG
• $cvs reversal underway plus $cura cbd news, looking to add more tmrw https://t.co/oup25IwqCW
• As an unabashed recreational consumer of dried flower cannabis I will share with consumers and @cvs that "CBD" as m… https://t.co/xh1DWrk2IY
• $CVS no he wasn’t... evasive...lol....stock will break out soon https://t.co/mB67grMHEs
• RT @BenjaminA_Smith: Great session for Curaleaf $CURA $CURLF , obviously. Yesterday's ER / $CVS deal was a defining event that could move i…
• Great session for Curaleaf $CURA $CURLF , obviously. Yesterday's ER / $CVS deal was a defining event that could mov… https://t.co/Vr2cxhwxip
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• CVS will now sell CBD products in 800 of their stores. Could be interesting which products and from what companies.… https://t.co/edk5m2CNg4
• $CURLF signs $CVS for #CBD, Blackrock invests in first US MSO, and banking reform hits next week without Jeff Session. Wow
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• @jimcramer I like that $CVS has made a bold move in carrying CBD Oils, but I'm more interested in @CVSI, an industr… https://t.co/2WxSIEROv6
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• CVS heard from its customers who use CBD, will 'walk slowly' in the space, CEO Larry Merlo says PUBLISHED THU,… https://t.co/8Lcg41Jw3d
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• Calling a 20% updside on $CVS Tomorrow long trades: CVS —>Long #cvs #WallStreet #StockoftheDay #Cannabis #upside https://t.co/pPqv1G4k99
• @ChazAltitude Which way the SPY goes is any ones guess but tomorrow my Lottos are on $CVS. I'm hit'n some options… https://t.co/R6evYY75tG
• RT @BenjaminA_Smith: Great session for Curaleaf $CURA $CURLF , obviously. Yesterday's ER / $CVS deal was a defining event that could move i…
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• Night Most Tweeted Big Caps, check out Gambiste Top 10: $TSLA $BIIB $TWTR $CGC $CVS $TWLO $ATVI $FB $NFLX $NKE https://t.co/k3uyuEtshh
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• RT @BenjaminA_Smith: Great session for Curaleaf $CURA $CURLF , obviously. Yesterday's ER / $CVS deal was a defining event that could move i…
• Covetrus $CVET & CVS Health $CVS Critical Survey https://t.co/edeSrGpc0r
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• @jimcramer They have good booze prices. Sorry, that's all I got on $CVS.
• RT @JBinGainesville: @ChazAltitude Which way the SPY goes is any ones guess but tomorrow my Lottos are on $CVS. I'm hit'n some options wit…
• Bright Rock Capital Management LLC Grows Holdings in CVS Health Corp (NYSE:CVS) https://t.co/FBPEhu6Ltj $CVS #stocks #stockmarket
• $AET $CEO $CVS CVS Health CEO on reducing costs: Billions in value opportunity is 'in front of us' https://t.co/EXbhW2ucxh
• Short sale volume(not short interest) for $RAD on 2019-03-21 is 60%. https://t.co/bUL9tsmgnO $GNC 51% $VSI 50% $CVS 43%
• @jimcramer The Chart of $CVS looks good. No worry. https://t.co/bs5h3g56BH
• $CVS: Bert’s March Dividend Stock Watch List: https://t.co/erQm9KDD4U
• Edge Wealth Management Trimmed By $460,915 Its Cvs Health $CVS Stake; Korea Electric Power $KEP SI Decreased By 6.8… https://t.co/gotIFO4XgQ
• most active stock options Thursday AM - $AAPL $MU $BAC $AMD $NVDA $NFLX $JPM $AMZN $FB $BA $MSFT $SQ $TSLA $BIIB… https://t.co/ImiJTjfoMT
• Interested in $CVS
• RT @Greenwillowfan: $CVS has started selling cannabis-based products in 8 states https://t.co/FS8n0nZL2d
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• Hey @CVSHealth $CVS how about this #CBD too>> "Elite Therapeutics Expands Product Offering To Include #CBD-Infused… https://t.co/H5C1ri3i2v
• RT @jimcramer: @JoeSquawk , @BeckyQuick , @WilfredFrost what does Mr. Bertolini, largest shareholder of $CVS think of Larry's work and the…
• @JoeSquawk , @BeckyQuick , @WilfredFrost what does Mr. Bertolini, largest shareholder of $CVS think of Larry's work… https://t.co/Nnn5pIO65S
• RT @jimcramer: Anyone feel emboldened to buy $CVS after the interview with Larry Merlo??
• @jimcramer I can’t believe $CVS is still under 60
• Morning Most Tweeted Big Caps, check out Gambiste Top 10: $TSLA $BIIB $TWTR $CGC $AMD $MU $DRI $ES $FB $CVS https://t.co/k3uyuEbRpJ
• Violich Capital Management Lifted Cvs Health $CVS Position by $3.28 Million as Stock Value Declined; Dumont & Blake… https://t.co/YpdZaPN28y
• @todd_harrison @Curaleaf_Inc @blackrock I sold prior to earnings. Hopefully I get another crack at it. I think the $CVS deal is $$$
• Spf Beheer Bv Has Trimmed Cvs Health $CVS Stake; Shorts at LEVON RES LTD ORDINARY SHARES CANADA $LVNVF Lowered By 4… https://t.co/oAQWE7cZ5y
• $CURLF gets $CVS deal for #cbd products... currently CBD's a $600M industry growing to an estimated $22B in the nex… https://t.co/WkS6XbWhmx
• RT @DonnaYoungDC: .@ChuckGrassley @RonWyden confirm all 5 #PBMs sending execs for April 9 @SenFinance #drugprices hearing: $CVS Derica Rice…

• $MDLZ Max Pain=47.00. Maturity=03/22/2019. #maxpain #options https://t.co/IhAcWydlop https://t.co/5VU95znr3b
• $MDLZ https://t.co/ji04Yaj00o
• #StocksToWatch in #WallStreet: $MSFT #Microsoft and other 82 stocks hits all-time-highs today: Several from my rec… https://t.co/vLObLc8pPd
• $MDLZ Mondelez ...BRB on the Weekly chart. Coming out of a massive consolidation area. https://t.co/WPKxCkEgzG
• All time highs hit $ABT $ADP $AMT $ANET $AZO $BAH $BLL $CCI $CDNS $COKE $COUP $CYBR $DATA $CRM $FICO $IAC $INTU… https://t.co/DRdHeVIKPM
• 94 - $KMB, $PAYC, $PM, $TWLO 93 - $CDNS, $MOH, $PPC 92 - $SYMC, $XLK 91 - $COST, $MDLZ, $NKE, $NOW, $TMO, $TTD
• As Mondelez Intl $MDLZ Share Value Rose, Brookstone Capital Management Has Lifted Holding by $374,400; As Middleby… https://t.co/RIwVOK0lop
• Mondelez International $MDLZ Stake Increased by United Services Automobile Association; Windsor Capital Management… https://t.co/ipanTpF9Eq
• BidaskClub top 50 #StronglyBought $INTC $TMO $ZTS $SCCO $LBRDA $MTCH $NVO $EC $EW $HDB $LYG $MCO $MDLZ $RBS $ISRG… https://t.co/8QKd1Bppnx
• $MDLZ technical alerts: Expansion Breakout, Reversal New Highs Setup, Slingshot Bullish, Upper Bo... https://t.co/Gsaejz3o3t
• 2019-03-21 Short sale volume (not short interest) for $TBT is 70%. https://t.co/4g0ir5UCoj $FCX 48% $PEP 42% $CMCSA 59% $MDLZ 50%

• RT @marketminute: Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.c…
• Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.co/MIYi3QOdcz
• Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.co/BBgfb01VJ6
• 3 Bank Stocks Whacked Down by the Fed $KRE https://t.co/CtPYdUEPoY $BAC $GS $AXP
• RT @marketminute: Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.c…
• RT @marketminute: Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.c…

• RT @marketminute: Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.c…
• Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.co/MIYi3QOdcz
• Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.co/BBgfb01VJ6
• RT @marketminute: Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.c…
• RT @marketminute: Market Feeds Bulls Artificially Flavored Green Jell-O $KRE $XRT $IYT $IWM $IBB $SMH Also $DIA $QQQ $SPY $BIIB https://t.c…
• $XRT $NFLX: HASTINGS REED (CEO) exercised options worth $333,334 and disposed stocks worth $19,265,104 https://t.co/N5vNJFHSQT
• $XRT $ULTA: HEILBRONN CHARLES (Director) disposed stocks worth $81,213,494 https://t.co/DLe18iPJZA
• $XRT $ULTA: Settersten Scott M (CFO) exercised options worth $4,557,702 and disposed stocks worth $9,999,831 https://t.co/mmshayjLFJ
• $XRT $ULTA: Dillon Mary (CEO) exercised options worth $19,859,128 and disposed stocks worth $40,448,116 https://t.co/E5ZMftMn4I
• $XRT $WMT: Foran Gregory S (VP) disposed stocks worth $7,401,988 https://t.co/ZazsYausLl

• $CELG $GILD CELG v GILD 2:17-cv-7639 updated - 2019-3-21 17:20:28 - MINUTES OF TELEPHONIC DISCOVERY CONFERENCE RE:… https://t.co/A6CMFAmVOS
• RT @haodongvli: $BIIB $GILD wasted lots of money on highly questionable internal clinical candidates, time to buy external pipelines! $XBI
• $SPY Support and Resistance (Pivots) for Fri 3/22/19: $GE $UPS $DIS $SNAP $ROKU $CMG $CAT $X $BIIB $CVS $BIDU… https://t.co/onooBX6s8m
• $GILD the bull pattern is not confirmed. A new bull pattern is detected. https://t.co/QhjvYSlP4Y
• #Biotechnology $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE… https://t.co/WV04qPetIS
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $SPX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS $BSX
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare $IBB $GILD $PFE $JNJ $BMY $CELG $MRK $AMGN $NVS
• #SCREENED $TWTR $FB $MU $DIS $T $VZ $JPM $GS $WFC $GILD $WBA $LVS $NIO $IYT $DIA $IWM $TNA
• $GILD: New Insider Filing on Director JOHN FRANCIS COGAN: https://t.co/izBmCh6O3d
• $QBIO Q BioMed Announced Strategic Partnership With SRI International for Formulation and Preclinical Development o… https://t.co/16BbleP0Cv
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/sGGioRcPG7
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/27UK2LtaiF
• $GILD new insider selling: 2700 shares. https://t.co/42UAoXuDJD
• $GILD Gilead Sciences, Inc. SEC Filing: Form 4 https://t.co/iuxuH1wIgm
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/cCWOVccdPB
• $GILD New Form 4 for Gilead Sciences From our Stock News Alerts App
• $GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/YK0YhCYhec
• Synthetic Biologics, Inc. $SYN Pioneering Cutting-edge Research into Clinical Science Designed to Protect and Prese… https://t.co/DStu2cMk7z
• Insider Selling: Gilead Sciences, Inc. $GILD Director Sells 2,700 Shares of Stock https://t.co/PenGhfOwqi #stocks
• Insider Selling: Gilead Sciences, Inc. $GILD Director Sells 2,700 Shares of Stock https://t.co/zIWSEujesy
• Gilead Sciences, Inc. $GILD Director John Francis Cogan Sells 2,700 Shares https://t.co/8uz38xadY1
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE… https://t.co/9i1I23miVr
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY $CELG $MRK $JNJ
• @Biomaven $AMGN hasn’t butchered shareholder value anywhere’s close to $GILD $CELG or $BIIB. Management hasn’t been… https://t.co/9WjDUHzUKd
• Don't miss our next FREE OPTION TRADE. Sign up for our Daily Free Trades at https://t.co/rBARpyozQn $NVDA $TSLA $GS $GILD $F $GOOGL $FB
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/rtYRt9hu0P
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/mPpvGqEiOm
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/uPV5cuthdR
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/hW8WSiKuQv
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/wu65v3lpJC
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/1LZWLo82cU
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/XFnslTcpob
• Big pharma has been dead money for some time now $BIIB $CELG $GILD $AMGN $ILMN $VRTX $GSK https://t.co/M0ILDsy6fn
• TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• We calculated 63-day Expected Return of $GILD for you: 1.41% https://t.co/mTgAzTSiLD
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/HwiQ0myqNg
• Wondering about risks of $GILD? The 21-day volatility is 5.5% https://t.co/YrfwPBdUuU
• $XBI $GILD: Cogan John Francis (Director) disposed stocks worth $175,689 https://t.co/voUupaPiK7
• $SPY $GILD: Cogan John Francis (Director) disposed stocks worth $175,689 https://t.co/voUupaPiK7
• All the shitty stocks had a decent run recently except this pos $GILD ... hmmm. Next? https://t.co/XZQTsvfps1
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/uaEHWiPAB5
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/Q5PTGmyiuD
• Weekly Stock Market Review Week #12: https://t.co/cUlRnZLnjL $AAPL $NVDA $MU $AMZN $FB $GOOGL $NFLX $SPY $QQQ… https://t.co/YdUztgyWb4
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/HcpIbyiDdH
• RT @nashbiotechs: 2019, THE NASH LANDSCAPE UPDATED https://t.co/uVNXB3qWqC $CNAT $GALT $GNFT $ICPT $AGN $GLMD $GILD
• RT @nashbiotechs: 2019, THE NASH LANDSCAPE UPDATED https://t.co/uVNXB3qWqC $CNAT $GALT $GNFT $ICPT $AGN $GLMD $GILD
• 2019, THE NASH LANDSCAPE UPDATED https://t.co/uVNXB3qWqC $CNAT $GALT $GNFT $ICPT $AGN $GLMD $GILD
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• RT @MomentumBeast: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/LDpddybNxj $IBB $GILD $NVS $PFE $BMY…
• RT @EquitiesOB: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/7ERv8DaAi8 $IBB $GILD $NVS $PFE $BMY $C…
• RT @PennyStockGang: TOP Biotech Stocks To Watch: $QBIO $GILD $BMY $CELG $NVS $MRK $JNJ
• RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $P…
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/735oG3ltLr $IBB $NVS $GILD $BMY $MRK $PFE $AMGN
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @MomentumBeast: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaste…
• RT @MomentumBeast: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/8p5…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @EquitiesOB: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/niWi1h…
• RT @EquitiesOB: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @NasdaqReporter: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/PV…
• RT @TodaysPenny: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/Xd1iF…
• RT @PennyStockGang: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/cG…
• RT @SmallCapTipsSs: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/GW…
• RT @274MicroCap: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead t…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster U…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @SmallCapTipsSs: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lea…
• RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://t.co/aksAIe…
• RT @247Biotech: $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corner guys!…
• RT @247Biotech: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in…
• RT @MomentumBeats: $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries…
• RT @MomentumBeats: $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may lead…
• RT @BehaviorFin: $CLLS $ALCLS When will we see sp back to $30 level? #TALEN and #ZncFng vs #crispr battle? $SGMO $CRSP $NTLA $EDIT $ALLO $P…
• RT @BehaviorFin: $CLLS $ALCLS Where is major part of #Cellectis' value? I begin to wonder whether biggest value of Cellectis is in human tr…
• RT @BehaviorFin: After buy out in #genetherapy of $ONCE, when would we see a buy out in #geneediting? $CLLS $ALCLS $SGMO $CRSP $NTLA $EDIT…
• RT @BehaviorFin: After buy out in #genetherapy of $ONCE, which area of next buy out? $ALNY $IONS $DRNA $ARWR $RGLS $MGEN $CLLS $ALCLS $SGM…
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/hGXowK9yUw
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/SoksZSdtRd
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/8V1XEaPTxr
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/wOkPKir5El
• $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University… https://t.co/fQhDZ0MsG0
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/U6OFizl2TQ
• ACTIVE TRADERS Try one of these FREE trading guides: https://t.co/fxBiNhe2er $NFLX $TSLA $AAPL $GILD $GS $FB $AMZN $GOOGL $NVDA
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• As Gilead Sciences $GILD Stock Declined, Arga Investment Management LP Has Lowered Position by $1.04 Million; Ameri… https://t.co/hbVfK4fIE1
• $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market https://t.co/A9tAAtixF0 … $IBB $NVS $GILD $BMY $MRK $PFE $AMGN $SPY
• Gilead Sciences $GILD Valuation Declined While Violich Capital Management Lowered Stake; Dumont & Blake Investment… https://t.co/dLiW1C9QkD
• RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. Pfizer pays $636M for rights to gene therapies, Novartis denies bribing Greek offi…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• Applied Optoelectronics $Call $AAOI Holder Polar Securities Has Lifted Position; As Gilead Sciences $GILD Valuation… https://t.co/8BS69WwuFF
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with Mc… https://t.co/N8aFwtQesl
• $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers… https://t.co/lWDoPm1UCm
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/Wha44CMfDw
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/QzUVt6Mo3n
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/9b0cnmxFPg
• #biotech highlights $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma… https://t.co/tEmnhlCUZR
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• $QBIO QBM-001 targets toddlers with pediatric developmental nonverbal disorder, where an underlying commonality may… https://t.co/SY3tEOlgQZ
• $QBIO Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Coun… https://t.co/zbrWOdOnzC
• $QBIO Q BioMed Inc recently acquired Cancer Pain Drug Metastron™ from GE Healthcare, Revenues right around the corn… https://t.co/xSBAPlxdwC
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…
• RT @247Biotech: $QBIO Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University https:/…

• Scan results - Expansion Breakout today: $GIII $CAG $DRI $BPY $MU $ACIA $QRVO $WPM $AAPL $BPR $MDCO $ANET $VCYT… https://t.co/DAwlfyI2PO
• Scan results - MACD Bullish Signal Line Cross today: $GIII $CAG $DRI $BPY $MU $BNFT $QRVO $BPR $FIS $EHTH $WIFI… https://t.co/CKEXwENFaz
• Called it re: $CAG upping trade. Also "non-IG SKUs". Lol... wtf is that? https://t.co/uAbr3OHSWG
• $CAG gapped up on #earnings and just kept running, closing up over 12%, making them Thursday's top performing $SPX… https://t.co/BAIM005aY4
• Scan results - MACD Bullish Centerline Cross today: $CAG $PETQ $ESTC $VIVO $SYNH $PRAH $PDCO $DEA $TTWO $SHOO $SCHN… https://t.co/mRdqsNDW59
• TOday’s Movers: Conagra Brands Inc $CAG Stock Rating Reaffirmed by Analysts at Jefferies; $44 Target Price Indicate… https://t.co/mSokxIekEn
• RT @vic_tradez: Very good day today, caught $SPI in premarket on the first pullback and got rid of it too soon. Just being cautious during…
• $CAG up 12.75% despite net income being down 25% for the 39 weeks ended Feb 24, 2019, as compared to the prior year… https://t.co/nlJiZkWw1m
• Also $cag charted it a few months ago with a bottom box - look at the initial breakout, retest - and boom move!! https://t.co/6VLrS170bM
• $CAG Up 12.75%, these people loaded almost 50M into long call. They are probably just lucky....right?? https://t.co/wBIcSWFaIK
• Here is a snapshot of the current market. Remember to join the discussion room for live analyses, trade recaps, and… https://t.co/4pUyvEUABs
• 1️⃣2️⃣Biggest Market Gainers $OOIL $SPI $SRNE $CURLF $DCIX $SCON $SOLO $SLNO $LIFE $VSI $STNE $CAG $TOPS $FLKS… https://t.co/cVgZuxmVsn
• Objectively a crap result by $CAG. Fundamentals are getting worse, the co get being strong armed into even more tra… https://t.co/oXNe3acPQV
• Bravo, right question to be asking on $CAG. All other Qs were just variations of "what number do I put into Excel c… https://t.co/X0lPJFSK9o
• Doubt it $CAG. Trade spend is like heroin to a retailer. Once you give it to them, they'll be made when you try to… https://t.co/G6wMEJfWbZ
• Wondering about risks of $CAG? The 63-day volatility is 22.22% https://t.co/4RK9AG69FQ
• Cynical move by $CAG mgmt - downgrades top line and GM guidance but upgrades EBIT on stripping out even more A&P. https://t.co/7lnSM9w4Gs
• #Options #maxpain chart for $CAG. Free options app https://t.co/wPNDm22czd https://t.co/JpgeUU9TD2
• Retailers capturing a lion share of $CAG's price/mix increases, and yet they still can't get more shelf space. https://t.co/FjvpwqsVDt
• Geez, PF's trends are even worse. $CAG paid $11bn / ~16x EBITDA for this? https://t.co/nRNjQpUfl3
• Lol, despite $CAG spending up on trade, TDP (proxy for shelf space) is still declining YoY. https://t.co/U8TCGHnxNR
• $CAG $MU $DRI $NVDA $MBT $AAPL $RLGY $ORCL $MSFT $CVS $F $LUV $T $NKE $CMCSA $CTAS $AMZN $GM $MUR $GOOGL $NFLX… https://t.co/RatS8UYZSS
• RT @tpetruno: Packaged food stocks, one of Wall St's most unloved sectors, surge after Conagra beats on earnings. Big movers: Conagra $CAG…
• $CAG $MU $DRI $NVDA $MBT $AAPL $RLGY $ORCL $MSFT $CVS $F $LUV $T $NKE $CMCSA $CTAS $AMZN $GM $MUR Major News-BULL… https://t.co/x3rg6Vpkob
• Todays Top Gainers: $SPI $SRNE $SLNO $DCIX $SOLO $SCON $CAG $VKTX $TOPS $STNE $ZSAN $OPK $MU $AMD $EA $WTI $TTOO $CRMD $WDC
• Check out that pole on $CAG @traderstewie @squeegene #PEG https://t.co/1KwHsfk47F
• $CAG Revenue grew by 35.7% https://t.co/Ml8KjerXuM
• 16 breakouts: $CAG (gap), $CURLF (gap), $GIII (gap and 200-day MA), $LVHD, $MGC, $MODN, $REET. Two sub-$0, four $1-2
• Few Equity highlights today: $GII Long 2pts Pivot cross into res. $AAPL 1.5pts flag break $AMD long aside options p… https://t.co/2yywLgtSnO
• $HBAN $URBN $EQT $TGT $FOXA $BIIB $CAG $RF $AAPL $NFLX $PEP $KEY $VIAB $FSLR $BK $AMD $DIS $ILMN $UNP $WY $MO $IBM… https://t.co/Td33yh4Dkd
• $CAG This was an Overnight #Earnings Play. I liked it for a lot of reasons, so I made the decision LIVE in Chat and… https://t.co/sTJNwl9RC5
• Gainers-3 $NDRA 13% $VSI 13% $TLSA 13% $CAG 13% $TOPS 12% $VAPO 12% $VKTX 12%
• RT @Fluctuationist: $CAG reported earnings of $0.51, consensus was $0.48 https://t.co/IIzTmtlWrv
• RT @LaMonicaBuzz: Another food company raised prices and its stock is soaring. ConAgra posts solid earnings, just like General Mills yester…
• Stocks to Watch for March 22, 2019 for $ACIA, $AERI, $AMD, $AXSM, $CAG, $EHTH, $SOLO, $SRNE, $STNE, $VCYT, $VKTX an… https://t.co/2zWiB9Xuwv
• Stocks to Watch for March 22, 2019 for $ACIA, $AERI, $AMD, $AXSM, $CAG, $EHTH, $SOLO, $SRNE, $STNE, $VCYT, $VKTX an… https://t.co/GBFgLWEOe5
• RT @UPBOptionMil: Some of todays top open interest changes 3.21.19 $AAPL $BMY $CAG $ALLY $VALE $PM $F $FIS $QCOM $CELG $DB $BBBY https://…
• The following companies are scheduled to report earnings tomorrow morning 03/22: $CVIA, $CSIQ, $GIII, $LE, $DRI, $ATU, $CAG, $CMC.
• You think positioning is still off sides? When a food company $CAG ConAgra is the top performer +12% out of my bra… https://t.co/emr9k07khJ
• RT @AjTrader7: TODAY'S LIVE TRADING WEBINAR RE-CAP FOR 3/21/2019 $ANET LONG $305 to $315 $SPI LONG $4.25-->$7.25 $PTE LONG $12.50-->$13.74…
• Sell-signal detected for 15 stocks: $CRM $CME $CERN $FTNT $MU $AIG $LRCX $URBN $AMD $VZ $CAG $BIIB $PXD $DRI $MKC
• Friday 22-Mar Earnings R2G watch: $CAG, $MU, $DRI @AOTtrades https://t.co/xiV6YlxpGe
• Wondering about risks of $CAG? The 21-day volatility is 5.04% https://t.co/pNeJOlDqGR
• Does $CAG have @petenajarian energy ⚡️? $GES $DRI $MU https://t.co/3eOTbetZXa via @YouTube
• @traderstewie Nice action in $CAG today. #PowerEarningsGap
• @Beutty Hi please find the unroll here: Thread by @linear_thinker: "Retailers capturing a lion share of $CAG's pric… https://t.co/66LWDb4eKh
• top money flow Thursday (share price x volume traded) - $AMZN $AAPL $BIIB $MU $AMD $NVDA $NFLX $BA $MSFT $DIS $FB… https://t.co/5ZqBbJ30KX
• Does $CAG have @petenajarian energy ⚡️? $GES $DRI $MU https://t.co/NoN6i7b9O2 via @YouTube
• Love your pun on $CAG $JPM. Did you see the 2 yr chart by any chance? $CAG was already under pressure before they b… https://t.co/lokW2PYzdH
• stocks with a high open interest of naked puts - $CELG $AAPL $PBR DIS $SNAP $BBBY $CZR $AMD $MU $COTY $AMD $MSFT $T… https://t.co/ioKR0hqRWD
• $CAG Conagra Rises Most Since 1989 as CEO Plots Pinnacle Turnaround via https://t.co/dU2ohMsCEH
• most active stocks on Thursday - $AMD $MU $BAC $GE $AAPL $F $HBAN $PBR $ITUB $CAG $ACB $ECA $VALE $SIRI $BBD $WFC… https://t.co/ZBSt9Ir9bb
• RT @AjTrader7: TODAY'S LIVE TRADING WEBINAR RE-CAP FOR 3/21/2019 $ANET LONG $305 to $315 $SPI LONG $4.25-->$7.25 $PTE LONG $12.50-->$13.74…
• RT @AjTrader7: $CAG This was an Overnight #Earnings Play. I liked it for a lot of reasons, so I made the decision LIVE in Chat and went ove…
• Conagra Brands $CAG Shares Up 12.8% Following Earnings Beat https://t.co/VgNnYzoczO
• watch list for tomorrow $RIOT, $ZSAN, $GLBS, $VSI, $BRS, $ROAN, $CAG, $YVR, $JAGX, $KPTI, $DARE, $SLNO, $TYHT, $TBLT, $NIO
• We calculated 63-day Expected Return of $CAG for you: -5.73% https://t.co/Yt2bD41x7G
• MACD Crossover $MU, $SPY, $GE, $GDX, $GG, $CAG, $PFE, $JNK, https://t.co/enk69n2wuO
• Thursday top % gainers >$10 by volume $AMD $MU $CAG $WDC $ATVI $AMAT $TME $EA $ON $STNE $WPM $DRI $STX $LRCX $PVTL… https://t.co/OfsV4SwO4S
• some new 30 day highs Thurs AM - $AAPL $CAG $NVDA $MSFT $EA $NFLX $QCOM $AMZN $DRI $WPM $TSM $MUR $TGT $PYPL $TWLO… https://t.co/3DqiYgRoXl
• #WiadomościRynkowe $AAPL $CAG $DRI $BIIB https://t.co/quVaJJdi2R
• most active stock options Thursday AM - $AAPL $MU $BAC $AMD $NVDA $NFLX $JPM $AMZN $FB $BA $MSFT $SQ $TSLA $BIIB… https://t.co/ImiJTjfoMT
• $SPI $CAG: 60 Biggest Movers From Yesterday: https://t.co/9Q03Pv5The
• RT @Turbobob129: Stocks to Watch for March 22, 2019 for $ACIA, $AERI, $AMD, $AXSM, $CAG, $EHTH, $SOLO, $SRNE, $STNE, $VCYT, $VKTX and $ZSAN…
• Conagra Brands, Inc. $CAG Analysts See $0.49 EPS https://t.co/xHdETIHHqa
• RT @TurboTradingbiz: Stocks to Watch for March 22, 2019 for $ACIA, $AERI, $AMD, $AXSM, $CAG, $EHTH, $SOLO, $SRNE, $STNE, $VCYT, $VKTX and $…
• RT @Turbobob129: Stocks to Watch for March 22, 2019 for $ACIA, $AERI, $AMD, $AXSM, $CAG, $EHTH, $SOLO, $SRNE, $STNE, $VCYT, $VKTX and $ZSAN…
• Conagra Brands $CAG Rating Increased to Hold at Zacks Investment Research https://t.co/mgKvAhRPKD
• Conagra Brands $CAG Rating Increased to Hold at Zacks Investment Research https://t.co/Z7eYaCeJhS
• $CAG technical alerts: Pocket Pivot, MACD Bullish Signal Line Cross, MACD Bullish Centerline Cross... https://t.co/M74nYdR77R
• Conagra Brands $CAG Releases FY 2019 Earnings Guidance https://t.co/N9LopRnMno
• Conagra Brands $CAG Issues FY19 Earnings Guidance https://t.co/8vrkbSi8Hp
• Conagra Brands $CAG Releases FY 2019 Earnings Guidance https://t.co/3sp9VN5AZn
• Conagra Brands $CAG Issues FY 2019 Earnings Guidance https://t.co/RigOFxHmuk
• @AOTtrades $CAG good PEG? As well as a "perma-long"?
• Conagra Brands $CAG Updates FY19 Earnings Guidance https://t.co/obcOdeiydZ